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ADL Activities of daily living
BDI Beck Depression Inventory
BMC Bone mineral content
BMI Body mass index
CAD Coronary artery disease
CHD Coronary heart disease
CI Confidence interval
CRP C-reactive protein
CV Coefficient of variation
CVD Cardiovascular disease
DNA Deoxyribonucleic acid
DOHaD Developmental Origins of Health and Disease
ELS Early life stress
HBCS Helsinki Birth Cohort Study
HPA Hypothalamus-Pituitary-Adrenal cortex
HUCH Helsinki University Central Hospital
IADL Instrumental activities of daily living
IGF Insulin-like growth factor
IGT Impaired glucose tolerance
IHD Ischaemic heart disease
IL Interleukin
INF Interferon
LTL Leukocyte telomere length
LTPA Leisure time physical activity
OR Odds ratio
PCR Polymerase chain reaction
RCT Randomized controlled trial
RNA Ribonucleic acid
RRR Relative risk ratio
SBP Systolic blood pressure
SD Standard deviation
SES Socioeconomic status
TNF Tumor necrosis factor
TRF Terminal restriction fragments
WHO World Health Organization
WWII World War II
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The proportion of those aged 60 years and older is expected to double from 12 
to 24 per cent by the year 2050. The prevalence of frailty increases rapidly with 
older age and is characterized by loss in biological reserve and resistance to 
stressors across several physiological systems. Frail people are at an increased 
risk of adverse health outcomes including hospitalization and premature 
mortality. Effective prevention of frailty requires knowledge on its risk factors
across the life course. The Developmental Origins of Health and Disease 
(DOHaD) hypothesis posits that early life influences may be important in 
determining disease risk in adulthood. There is evidence of early life influences 
in the pathogenesis of chronic diseases including cardiovascular disease and 
type 2 diabetes. The aim of the present study was to investigate early life 
exposures and frailty from a life-course perspective.
The present study uses data from the Helsinki Birth Cohort Study that 
includes 8,760 individuals born in Helsinki in 1934-1944. A random subset of 
participants (n=2,902) was invited to participate in a baseline clinical 
examination; of those 2,003 participated in 2001-2004. Of these, 1,094 out of 
the invited 1,404 participated in a follow-up clinical examination in 2011-2013. 
Frailty was measured at the follow-up examination using the Fried phenotype 
model in participants with a mean age of 71 years. Data on infant and 
childhood development and exposures were extracted from healthcare records 
and national registers.
Weight, length and body mass index (BMI) at birth were inversely 
associated with the presence of frailty in both sexes. Men who were frail in old 
age had experienced accelerated BMI gain from the age of 2 to 11 years 
compared to non-frail men. Similarly, men who as boys experienced wartime 
separation from both parents were at an increased risk of frailty compared to 
non-frailty. No similar associations were observed in women. Those who 
worked in manual labor occupations as adults were at an increased risk of 
frailty compared to those who worked as officials. Short leukocyte telomere 
length at the mean age of 61 years was associated with frailty at the mean age 
of 71 years. Furthermore, frail individuals had shorter telomeres at the mean 
age of 71 years compared to non-frail individuals. No association between 
telomere shortening and frailty was observed.
Several life-course determinants of frailty were identified. Associations 
between factors taking place during gestation and early life suggest that 
susceptibility to frailty may be programmed early in life. Moreover, the 
association between BMI growth and wartime separation and frailty may vary 
by sex. Leukocyte telomere length may be a meaningful frailty biomarker in its 
ability to detect processes that are associated with frailty. The prevention of 
chronic disease and frailty should start already at a young age e.g. through the 
promotion of the health of mothers in childbearing age.
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Yli 60-vuotiaiden osuuden väestöstä ennustetaan tuplaantuvan 24 prosenttiin 
vuoteen 2050 mennessä. Gerastenian (suom. ger=vanha ja astenia=heikkous)
vallitsevuus kasvaa voimakkaasti ikääntymisen myötä, ja sitä luonnehtivat 
alentuneet biologiset voimavarat sekä heikentynyt vastustuskyky 
stressitekijöille useassa elinjärjestelmässä. Gerastenisen henkilön edellytykset 
palautua stressitekijän jäljiltä ovat alentuneet, ja gerastenia on yhteydessä ei-
toivottuihin terveystapahtumiin, kuten sairaalajaksoihin ja ennenaikaiseen 
kuolleisuuteen. Tehokas gerastenian ehkäisy edellyttää tietoa sen 
riskitekijöistä. Terveyden ja sairastavuuden kehityksellistä alkuperää
tarkasteleva DOHaD-hypoteesi korostaa varhaisen elämän merkitystä 
aikuisiän sairastuvuuteen. Aikaisemmissa pitkittäistutkimuksissa on havaittu 
yhteyksiä varhaiselämän altistusten ja kansansairauksien, kuten sydän- ja 
verisuonisairauskien ja tyypin 2 diabeteksen, välillä. Tutkimuksen tavoite oli 
tutkia gerasteniariskiä elämänkaaren näkökulmasta.
Tutkimus on Helsingin syntymäkohorttitutkimuksen osatutkimus, ja 
siihen sisältyy 8760 Helsingissä vuosina 1934–1944 syntynyttä henkilöä. 2902 
satunnaisesti kutsutusta henkilöstä 2003 osallistui kliiniseen tutkimukseen
vuosina 2001–2004. Heistä 1,404 kutsuttiin jatkotutkimukseen, johon 
osallistui 1094 henkilöä vuosina 2011–2013. Gerastenia määritettiin 
seurantatutkimuksen yhteydessä keskimäärin 71 vuoden iässä käyttäen 
Friedin fenotyyppimääritelmää. Tieto elämänkaaren aikaisista riskitekijöistä 
saatiin terveydenhuollon asiakirjoista ja kansallisista rekistereistä.
Syntymäkoko oli kääntäen verrannollinen gerasteniariskiin. Gerasteniset 
miehet kasvoivat muista miehistä poiketen: lapsuudessa heidän 
painoindeksinsä kasvoi nopeammin 2-11 ikävuoden aikana ei-gerastenisiin 
miehin verrattuna. Samoin miehet, jotka olivat lapsuudessaan sotalapsia, 
sairastuivat useammin gerasteniaan keskimäärin 71 vuoden iässä. Vastaavia 
yhteyksiä ei havaittu naisten keskuudessa. Aikuisiässä tehdastyötä tehneillä 
oli lisääntynyt riski gerasteniaan. Niillä henkilöillä, jotka olivat gerastenisia 
keskimäärin 71 vuoden iässä, oli keskimäärin lyhyempi telomeeripituus 61 ja 
71 vuoden iässä. Yhteyttä telomeerien lyhenemisen ja gerastenian välillä ei sen 
sijaan havaittu.
Tässä väitöstutkimuksessa tunnistettiin useita elämänkaaren aikaisia 
riskitekijöitä gerastenialle. Yhteydet varhaisen elämän ja gerastenian välillä 
viittaavat, että alttius gerasteniaan voisi syntyä jo varhain elämässä. Kasvun ja 
sotalapsuuden yhteys gerasteniaan voi sen sijaan olla sukupuolesta 
riippuvainen. Valkosolujen telomeeripituus saattaa olla hyödyllinen 
gerastenian biomarkkeri johtuen sen kyvystä havaita gerastenialle altistavia 
prosesseja. Kroonisten sairauksien ja gerastenian ennaltaehkäisyn tulisi alkaa 
jo varhaisemmalla iällä esimerkiksi tukemalla raskaana olevien äitien 
terveyttä.
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Andelen över 60-åriga personer förutspås fördubblas och uppgå till 24% år
2050. Gerasteni är en geriatrisk sjukdom som innebär att individen inte har 
tillräckliga förutsättningar för återhämtning från små förändringar i 
hälsotillståndet på grund av nedsatt stresstolerans i flera organsystem. 
Gerasteni, som blir allt vanligare med tilltagande ålder, karakteriseras av en 
ökad risk för sjukhusvård samt ökad dödlighet. Ökad kunskap om riskfaktorer 
för gerasteni kan möjliggöra prevention av sjukdomen. Enligt DOHaD-
hypotesen kan förhållanden under det tidiga livsskedet påverka den framtida 
hälsan i stor utsträckning. Longitudinella studier har påvisat att kroniska 
sjukdomar så som kranskärlssjukdom och typ 2 diabetes har riskfaktorer som 
härstammar från spädsbarnsålder och tidig barndom. Avhandlingens syfte var 
att studera gerasteni ur ett livcykelperspektiv.
Denna delstudie av Helsingfors födelsekohortstudie inkluderar 8760 
individer som föddes i Helsingfors under åren 1934–44. Av de 2902
slumpmässigt inbjudna deltog 2003 i en klinisk studie under åren 2001–
2004. Sammanlagt 1404 individer kallades till en uppföljningsstudie under 
åren 2011–2013 varav 1094 deltog. Gerasteni definierades enligt 
fenotypmodellen i medeltal vid 71 års ålder. Information om tidiga 
riskfaktorer för gerasteni erhölls ur nationella hälsovårdsregister samt andra 
register. Information erhölls även från de kliniska undersökningarna.
Ett omvänt förhållande mellan vikt, längd och BMI vid födseln å ena sidan
och å andra sidan gerasteni konstaterades. De gerasteniska männen upplevde 
en annorlunda tillväxt i barndomen än de övriga männen: deras viktindex
ökade snabbare än viktindexet bland de icke-gerasteniska männen från 2 till 
11 års ålder. De män som i barndomen varit krigsbarn insjuknade oftare i 
gerasteni. Inga liknande samband hittades bland kvinnorna i studien. En lägre 
socioekonomisk ställning i vuxen ålder var förknippad med en ökad risk för 
gerasteni. Individer som var gerasteniska vid 71 års ålder hade kortare 
telomerlängd vid 61 och 71 års ålder jämfört med dem som inte var 
gerasteniska. Inget samband mellan telomerförkortning och gerasteni 
konstaterades.
Flera tidiga riskfaktorer för gerasteni konstaterades i studien. Sambandet
mellan olika faktorer i det tidiga livsskedet och gerasteni i ålderdomen påvisar 
att risken för gerasteni kan programmeras redan tidigt i livet. Den tidiga
tillväxtens och stressens inverkan förefaller vara olika hos män och kvinnor. 
Telomerlängden kan vara en meningsfull biomarkör för gerasteni. Man borde 
redan i ett tidigt livsskede börja förebygga kroniska sjukdomar och gerasteni
t.ex. genom att stöda hälsan hos gravida kvinnor.
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Globally, the mean ages of populations are increasing. The fastest growing age 
group is those aged 60 and older, whose proportion of the global population is 
expected to double from 12 % to 24 % by the year 2050. With decreasing 
fertility and increased longevity many developed nations are facing an ageing 
crisis. (1)
Frailty, a geriatric syndrome of which the prevalence increases from 3.2 % 
at the age of 65-70 years to 16.3 % at the age of 80-84 years when Fried frailty 
phenotype criteria were used (2), constitutes a major challenge to ageing 
societies worldwide (3). Frailty, according to the Fried criteria, can be defined
as the presence of three or more of the following criteria: exhaustion, weight 
loss, weakness, low physical activity and slowness (2). Frail individuals fail at 
recovering from minor changes in their health status due to decreased 
physiological reserves across several organ systems (2,4). Consequently, they 
are at increased risk of adverse health outcomes including falls, fractures, 
hospitalization, disability, nursing home admission and premature mortality
(5–10).
Prevention of frailty has been a public health priority for several ageing 
societies (11). Effective frailty prevention requires knowledge on its risk 
factors. Several adulthood risk factors of frailty, including older age, obesity, 
smoking, polypharmacy, multimorbidity and poor cognitive and physical
functioning, have been identified (2,12–14). The understanding of complex 
ageing-associated diseases, however, requires a life-course approach (15,16).
Life-course epidemiology studies the long-term associations between
exposures that take place during gestation, childhood, adulthood and health 
in later life (17). Few studies have investigated frailty from a life-course 
perspective and little is known about its early life origins. Previous studies 
have shown that factors which the individual is exposed to in utero and early 
infancy were associated with chronic diseases including cardiovascular disease
and type 2 diabetes through a phenomenon known as ‘programming’ (18–21). 
Exposures that take place during sensitive phases in development can have 
permanent and long-lasting effects on later health. For example, rats that were 
exposed to undernutrition during gestation were smaller, grew slower and 
aged faster than rats that were not exposed to undernutrition in utero. (22)
The present study aims at studying frailty from a life-course perspective in 
the Helsinki Birth Cohort Study among 1,078 individuals born in 1934-1944.
We investigated associations between factors and exposures taking place 
during gestation, childhood, adulthood and later life and frailty at the mean 
age of 71 years.
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Evidence from animal studies suggests that exposures taking place during 
critical phases in development may have long-lasting and even lifelong effects 
on later health. When a female rat was injected with testosterone on the 5th
day after birth, development continued normally until puberty. In puberty, 
these rats failed to ovulate and express normal sexual behavior due to 
irreversibly altered function of the hypothalamus. When testosterone was 
injected to female rats on the 20th day after birth, no similar effects were
observed, and the rats expressed normal sexual behavior (23). The experiment 
suggested that development of reproductive traits could be permanently 
changed during sensitive periods in development. Another example from 
rodents is the observation of accelerated aging in rats undergoing 
undernutrition in utero. Rats that were exposed to undernutrition in utero and
up to three weeks after birth experienced on average a more rapid progression 
in albuminuria and other aging-related physiological changes than rats that 
received adequate nutrition (24). Moreover, in another experiment where rats 
were exposed to undernutrition in utero but then given adequate nutrition in 
postnatal life, a significant reduction in their lifespans was observed (25).
A study published in The Lancet in 1986 showed that ischaemic heart 
disease (IHD), which had gradually become more prevalent with increasing 
prosperity and quality of life, was not nearly as deadly for others as for some
(26). By comparing infant mortality rates in England and Wales in 1921-1925 
to mortality rates from IHD in the same areas in 1968-1978, David Barker and 
colleagues were able to point out that the areas where more people died of IHD
had had higher than average infant mortality rates some half a century earlier. 
They suggested that it was malnutrition that occurred early in life which
predisposed some individuals to the harmful effects of a diet associated with 
affluence and IHD. A few years later, findings from a cohort of 5,654 men born 
in Hertfordshire, England, between 1911 and 1930, showed that lower than 
average size at birth and at 1 year of age were associated with increased
mortality from IHD. Combined small size at birth and at 1 year were associated 
with highest mortality from IHD. (27)
The role of lifestyle-related factors in chronic disease pathogenesis was 
known during those times. With passing years, the findings of Barker and 
colleagues were confirmed in other populations and extended to include other
determinants and outcomes. As a result, the Foetal Origins Hypothesis, or the 
Barker Hypothesis, was born. The hypothesis states that foetal undernutrition
that takes place during critical phases of gestation may result in abnormal 
growth of the foetus, and through permanent changes in the newborn, affect 
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adult chronic disease risk (28). Further research suggested mediating and 
independent effects of events occurring at sensitive periods after the foetal 
period, primarily in infancy and childhood. The Developmental Origins of 
Health and Disease (DOHaD) hypothesis examines adult disease from the 
perspective of all of development and related sensitive periods.
A central part of the DOHaD hypothesis is programming (21). 
Developmental plasticity refers to the ability of the developing foetus to pick 
up subtle cues from the environment during critical periods in development. 
These cues serve as important predictors of the postnatal environment, and by 
being plastic, the foetus may facilitate changes to its biology to better adapt to
this environment. These changes are often irreversible and cannot be modified 
outside of critical phases in development. (29,30) A match between 
intrauterine conditions and those encountered later in life would result in 
beneficial adaptive changes and increased survival. However, in contemporary 
conditions where food has become more available to humans worldwide, a
predicted postnatal life of limited nutrition is less frequently matched. This 
results in the mismatch of pre- and postnatal conditions. This mismatch could
facilitate changes in biology that may, in the long term, lie on the pathway to 
chronic disease. (19)
The mechanisms by which the foetus is programmed are complex and likely 
to involve changes in hormonal, metabolical and physiological systems (Figure 
1). Interactions between the environment and foetal genes may result in
epigenetic changes in which gene expression is altered without modifying the 
deoxyribonucleic acid (DNA), with effects observed to extend over several 
generations. Results from experiments done with animals stress the 
importance of timing, intensity and duration of stressors in determining their 
significance (31). For example, when the foetus is challenged during a period 
of maternal caloric restriction, growth of vital tissues e.g. the brain is 
prioritized over those in skeletal muscle and kidneys (32). Similarly, growth 
retardation can be induced by hypoxic conditions in high altitudes (33) or by 
carbon monoxide as the result of cigarette smoking (34).
Other maternal factors such as high levels of stress and oral use of 
glucocorticoids have been found to influence hormonal pathways of the foetus, 
namely that of the hypothalamus-pituitary-adrenal (HPA) axis, through 
increased levels of circulating hormones. These circulating hormones have 
been suggested to modify organogenesis, receptor regulation and sensitivity to 
feedback mechanisms in not only the HPA axis but also in other parts of the 
body. Alterations in DNA methylation, expression of regulatory genes and 
noncoding ribonucleic acid (RNA) molecules have been targeted as possible 
pathways to modify the foetal epigenome. (35) Furthermore, other hormones 
including growth hormone, insulin-like growth factors (IGFs), thyroid 
hormones as well as those secreted by the placenta have been suggested to be 
involved, although to a lesser extent (36).
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Body size at birth, and birth weight in particular, have been considered to be 
crude markers of the intrauterine environment in adult cohorts that have 
limited data on foetal growth. The universality and high recall rate together 
with documented low recall bias support the use of birth weight in 
epidemiological studies (38,39).
Studies examining the association between birth weight and outcomes in 
neonates and infants report that children born below a certain size are at 
increased risk of health difficulties and premature mortality. Furthermore, 
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rather than being linear, this risk has been described to increase exponentially
with decreasing birth weights. The World Health Organization (WHO) has 
defined ‘low birth weight’ as measured weight at birth that is below 2500 
grams. (40)
Several factors which are known to affect birth weight have been identified, 
summarized in Figure 2. Mothers of short stature and smaller size give birth 
to smaller babies. Toxins such as cigarette smoke or alcohol, and deprivation 
of nutrients e.g. during maternal undernutrition, have been associated with 
smaller birth weight. Nutrients are transported to the developing foetus 
through the placenta and disturbances in its function can also affect nutrient 
intake of the foetus. The parents’ genetic information is transferred to the 
foetus, which has its own unique genotype. Gene-environment interactions, in 
which altered gene expression may occur without changes to DNA itself, may 
affect birth weight through epigenetic signalling. (40,41)
The original findings of Barker and colleagues linking low birth weight with 
later IHD (27) have since been extensively replicated in cohorts worldwide
(42–48). A meta-analysis of studies on birth weight and later coronary heart 
disease (CHD) risk suggested that per each 1 kg increase in birth weight the
relative risk of CHD was reduced by 10-20 %, and that being small at birth 
(birth weight <2500 g) would increase later CHD risk (49). Birth size has been 
linked with several non-communicable diseases in adulthood (Table 1).
Small birth weight has since been associated with risk factors for CHD. An 
inverse relationship between birth weight and systolic blood pressure (SBP) in 
adulthood (50) was later extended to include low birth weight as a risk factor
for hypertension in both men (51) and women (52). Results from a meta-
analysis of 31 studies suggest that while hypertension is more prevalent among 
17
children with high birth weight, this trend is reversed in adulthood and later 
life, showing a protective effect from hypertension in adulthood among those 
who had higher birth weight (53). Evidence from studies assessing the 
association between birth weight and stroke risk suggest that a low birth 
weight may result in increased subsequent risk of stroke (44,47,54,55).
The association between birth weight and diabetes has been studied in 
several cohorts. Initially an inverse association between birth weight and type 
2 diabetes (20,51,56,57) has since been extended to include both extremes, 
resulting in a U-shaped association between birth weight and the risk for type 
2 diabetes (58). Conversely, high birth weight alone was found to be associated 
with type 1 diabetes in a meta-analysis of 12 cohorts (59). Similarly, high birth 
weight has been associated with a higher prevalence of adult obesity (52,60)
and autoimmune diseases including rheumatoid arthritis (61,62) and 
Sjogren’s syndrome (63).
Low weight at birth has been associated with mental health disorders such 
as depression in adulthood (64). Although with varying heterogeneity, this has 
also been replicated in more recent meta-analyses (65,66). Furthermore, 
evidence from meta-analyses report on associations between low birth weight 
and chronic diseases and conditions such as asthma (49), decreased lung 
function (67), decreased bone mineral content (BMC) (68,69) and chronic 
kidney disease (70,71).
The role of birth weight in determining subsequent cancer risk may depend
on tumour type. While low birth weight has been found to be associated with 
an increased risk of testicular cancer (72), high birth weight has been found to 
be associated with malignancies of the breast (73), prostate (74) and bone 
marrow (75) in meta-analyses of observational cohorts. Mortality from all 
causes was greater in those with births weights of 2500 grams or less than 
those with a normal birth weight. Low birth weight has been associated with 
mortality from cancer in men but not among women. (76)
Birth weight and examples of some associated conditions
Low birth weight High birth weight
Coronary heart disease Obesity
Cerebrovascular disease Type 1 diabetes
Hypertension Type 2 diabetes
Type 2 diabetes Certain cancers
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No previous studies assessing associations between measures of size at birth 
and walking speed, exhaustion and weight loss were found. However, studies 
that have examined the association between birth weight and leisure time 
physical activity (LTPA) in late adulthood (77–79) report a trend of lower 
LTPA in groups with the lowest birth weight. However, birth weight was not 
associated with LTPA in a study focusing on strenuous LTPA in midlife (80).
A meta-analysis including 13 studies suggested strong associations between 
extremes of both low and high birth weight and decreased LTPA but very weak 
associations in birth weights that were considered to be within normal range
(81).
Similarly, a positive association between birth weight and grip strength in 
early (82–85) and late adulthood (86–88) has been observed. Furthermore, a 
study that assessed birth weight and longitudinal grip strength trajectories 
found that men born small reached a lower peak grip strength in midlife (89). 
Results from a meta-analysis showed positive associations between birth 
weight and grip strength measured at many points during life (90).
The association between birth weight and frailty has been assessed in the 
Dutch famine cohort. In that study, a graded yet non-significant trend of 
decreasing birth weight with increasing frailty classification was observed. 
With few frail individuals the study lacked in statictical power. (91) Moreover, 
a study assessing hereditary and environmental frailty determinants among 
1,642 twin pairs aged 40-84.5 years showed that age and birth weight 
contributed to 11.9% of the variance in the used frailty definition. However, in 
this study of twins, birth weight was self-reported (range 0.793 to 4.129 kg) 
and, on average, low (mean 2.382 kg). (92)
Infancy refers to the period of rapid growth and development ranging from 
birth to the approximate age of 2 years. Following infancy, childhood spans 
the ages of 2 to 11 years. Both infancy and childhood include different 
developmental milestones and mechanisms (93).
Adiposity increases in early infancy and decreases in childhood. In early 
childhood, within the approximation of ages 5 to 7 years, adiposity starts to 
increase again. The age at which adiposity starts to increase in childhood, 
termed as ‘adiposity rebound’ or ‘body mass index (BMI) rebound’, is 
important in predicting adiposity in adult life. Those who experience adiposity 
rebound earlier have on average higher adiposity in adulthood. (94) In the 
Helsinki Birth Cohort Study (HBCS), the cumulative incidence of type 2 
diabetes in adulthood was observed to be higher among those experiencing 
BMI rebound before the age of 5 years (8.6%) than for those in whom it 
occurred at the age of 7 years or later (95).
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While prenatal exposures are important factors in influencing later health, 
they may to some extent be modified by postnatal growth. The human body is 
highly adaptable to changes in the environment, but when these circumstances
become highly polarized, they become ‘mismatched’. For example, 
undernutrition in utero may result in changes to metabolism that aim to 
optimize the use of nutrients in later life. However, facing excess nutrition, 
these mechanisms may not be beneficial and result in accelerated growth in 
body size. (19) Size at birth and patterns of postnatal growth have been linked 
with certain adult disease (Table 2).
In the HBCS, those men who as adults were admitted to hospital due to 
coronary artery disease (CAD) had on average been small at birth and 
remained small until the age of 2 years, after which they rapidly grew in weight 
and BMI reaching the cohort average by the mean age of 11 years. In the same 
study cohort, a similar finding was also observed in women. The women also 
remained small in the first 2 years of life, but in childhood they caught up faster 
with the rest of the cohort, finally being above the cohort average in weight and 
BMI by age 11 years. (18)
The pattern of growth which has been associated with adult hypertension 
closely resembles that of CAD. Participants with previously diagnosed 
hypertension (for example for receiving state reimbursement for hypertension 
medication) had been small at birth and they had experienced little change in 
mean Z-scores for height and weight until the age of 2 years. By the age of 11 
years, they had caught up with the rest of the cohort in weight, height and BMI. 
A different pattern of growth was identified in participants with newly-
diagnosed hypertension. Those with mean systolic blood pressures of 140 
mmHg or higher or diastolic blood pressures of 90 mmHg or higher at the 
examination had not been small at birth but after birth their average weight, 
height and BMI fell below the cohort average and remained below average 
throughout childhood to the age of 11 years (96). A similar pattern of growth 
has been linked with a higher stroke incidence (97). In boys with average or 
high birth weight, growth-velocities for BMI and height between 8 to 13 years 
were associated with hypertension at the mean age of 51 years, whereas no 
associations between childhood growth and hypertension were observed 
among girls (98). In individuals aged 26-32 years from Delhi, India, rapid BMI 
gain from birth to the age of 11 years was associated with elevated blood 
pressure levels in adulthood (99).
Certain patterns of growth have also been associated with metabolic 
diseases. A pattern of accelerated BMI and weight gain compared with the 
cohort mean from birth to the age of 11 years was associated with obesity and 
the metabolic syndrome at age 26 to 32 years in the New Delhi cohort (99). In 
a cohort of Finns, participants who developed the metabolic syndrome had 
weighed less at birth and were thinner from birth to 7 years of age (100). In a 
cohort of Indians aged 26 to 32 years, those who had developed impaired 
glucose tolerance (IGT) or type 2 diabetes by the age of 32, had on average had 
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a low BMI until the age of 2 years but had then caught up in BMI by the age of 
12 years (101). Again, those with a low BMI at the age of 1 to 4 years followed 
by high BMI were observed to be at an increased risk of IGT or diabetes in 
adult life (99). Among older Finnish participants, those who later developed 
type 2 diabetes had been small at birth, caught up with the others by the age 
of 7 years, and between the ages of 7-15 years, experienced accelerated weight 
gain (20).
Patterns of growth have also been linked with impairments in lung 
function, decreases in BMC and prevalent depressive symptoms (102–105). In 
terms of mortality, differences in patterns of growth have been observed 
among men and women. While an increase in all-cause and cancer mortality 
was observed among women who as girls experienced accelerated BMI growth,
men with higher cancer mortality rates tended to have retarded BMI growth 
in childhood. (106)
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There are currently no previous studies that have reported findings on early 
growth and frailty. However, studies have explored associations between early 
growth and some of the frailty criteria. Findings regarding the association
between postnatal growth and later grip strength have not been consistent in
men and women. Accelerated weight gain during the first year of life was found 
to be associated with better grip strength in young (107) and older men (108). 
Bigger body size at ages 2 (weight for length z-score) and 4 years (height for 
age z-score) was associated with better grip strength more consistently among 
men than women. Furthermore, these associations were observed to be 
mediated by adult lean mass (85). In another study, 1-standard deviation 
increases in height growth velocities between the ages of 2 and 7 years were
associated with better grip strength in both sexes combined, whereas between 
the ages of 7 and 15 years, 1-standard deviation increases in weight gain 
velocities in men and height gain velocities in women were associated with 
better grip strength at the mean age of 53 years (109).
No studies were found which assessed the association between early growth 
and later walking speed. However, some studies assessing the effects of early 
growth on later physical performance and functioning included components 
of walking distance and physical activity in their composite outcome variables. 
While conditional infant growth was not associated with physical performance 
in one study (110), another study using the physical functioning sub-scale of 
the Short Form 36 survey reported an association between infant growth and 
better physical functioning score at the mean age of 61 years (111). In contrast, 
other studies have reported associations between early growth and physical 
performance in men (112) and for both sexes combined (113). No studies on 
early growth and other frailty criteria including exhaustion and weight loss 
were identified.
Stress has been defined as “a state in which homeostasis is actually threatened 
or perceived to be so [and] homeostasis is re-established by a complex 
repertoire of behavioural and physiological adaptive responses of the 
organism” (114). Evidence from animal studies suggests that early exposure to 
either stress or glucocorticoids may result in reprogramming of the HPA-axis, 
and altered neurodevelopment, cognition and mental health (115–118). Early 
life stress (ELS) includes these changes to homeostasis that occur within the 
timeframe from early gestation to puberty due to either social, psychological 
or physical events (119).
In humans, early life stressors may include maternal factors such as intake 
of exogenous glucocorticoids or infections (120), factors involving the child’s 
living environment such as maltreatment or abuse (121,122), or tragic life 
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events in childhood including the loss of a parent through divorce or death
(123,124).
Mental health and well-being are among the most studied outcomes of ELS. 
Former Finnish war evacuees, who had been evacuated to Sweden or Denmark 
as children during World War II (WWII), reported significantly more severe 
depressive symptoms in the 6th decade of their life than those who had not 
been evacuated (125). Among former British WWII evacuees, poor foster care 
was associated with depression in old age (126). Furthermore, wartime 
separation has been associated with later risk of severe mental health 
disorders, namely substance misuse and personality disorders (127,128), and 
in general, former war evacuees report lower levels of psychosocial well-being 
than non-evacuees (129). Poor mental health and reduced mental health 
related quality of life in adulthood have been associated with neglect and abuse 
in childhood (130,131).
Evidence suggests that ELS may affect later health behavior. Self-reported 
adverse childhood experiences were associated with alcoholism, drug abuse, 
smoking, physical inactivity, depression and suicide attempts in a sample of 
the U.S. population aged 19-92 years (132). Similarly, associations between 
adverse childhood experiences and obesity (132,133) and chronic pain (134)
have been reported.
Children who had been subjected to abuse or maltreatment reported lower
levels of physical health and quality of life in later life (130,131,135). 
Furthermore, those who reported having had adverse childhood experiences
had higher rates of cardiovascular disease (CVD) as adults than those who did 
not (132,134,136), even after adjusting for other risk factors for CVD (137). 
Similarly, the prevalence of CVD has been observed to be greater among 
former war evacuees than non-evacuees (138,139). Moreover, childhood 
wartime experiences have been linked with later blood pressure levels
(138,140,141).
Childhood neglect has been associated with an increased risk of diabetes in 
adulthood (136). Furthermore, a higher prevalence of diabetes has been 
observed among those experiencing childhood adversities than among those 
who reported no childhood adversities (134). Among former war evacuees, 
those who had been separated from both parents during WWII were more 
frequently diagnosed with type 2 diabetes compared to those who had not been
separated (138). Besides diabetes, ELS has been associated with a number of 
other diseases including pulmonary disease, bowel disease, liver disease, 
arthritis and cancer (132,134,136,142,143).
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There is little evidence on the association between ELS and frailty or frailty 
criteria. In a cross-sectional study of 2,002 individuals aged 65-74 years where 
information on self-reported childhood physical abuse and frailty was 
available, a higher proportion of frail (17.8%) than non-frail (9.7%) 
participants reported having experienced physical abuse in childhood. In that 
study, childhood physical abuse was associated with frailty in the crude model 
but was attenuated after adjustment for covariates including age, gender, 
education and study site. (144)
During somatic cell division, replication of the two DNA strands is initiated by 
DNA polymerase, an enzyme that requires RNA primers with 3’ hydroxyl 
groups paired to the template strand. As DNA polymerase moves along to 
replicate the DNA, the RNA primers are discarded. This leaves a gap of missing 
genetic information at the ends of the newly built DNA, which in the absence 
of telomeres would lead to loss of genetic material with each cell division. (145)
Telomeres are tandem TTAGGG repeats located at the ends of eukaryotic 
chromosomes. Their structure, a protein complex, is dynamically assembled 
and disassembled in cycles. The primary function of telomeres and associated 
enzymes is to maintain chromosomal integrity by enabling full replication of 
the DNA strands. Instead of chromosomal DNA, some of the repeat sequence 
of the telomere is lost with each somatic cell division. In contrast, the enzyme 
telomerase can add new repeats to the telomere. When the telomeres are 
critically short, the cell no longer proliferates thus entering senescence, and 
ultimately, apoptosis. (146)
Disparities in telomere length begin from as early on as in the womb as the 
result of various environmental and genetic factors. Consequently, variability 
in leukocyte telomere length (LTL) can be already detected at birth. (147) After 
birth, it is suggested that LTL undergoes rapid shortening until the 2nd decade
after which this rapid shortening slows down (148–150). A recent study of 4 
longitudinal cohorts studying age-dependent shortening of LTL across six 
decades of adult life suggested that the rate of LTL shortening would be 
relatively stable during adulthood and that differences in the rates at which 
LTL shortens would mostly be attributed to factors that originate early in life
(151). Among adults and older individuals, women have consistently been 
reported to have longer LTL, and during a given period, women experience 
less of telomere shortening than men (152,153). Male sex, smoking and 
physical inactivity have been associated with shorter telomere length, and 
variation in telomere length has also been observed across different ethnic 
groups (154).
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The availability of peripheral blood leukocytes in blood samples, high quality 
of their DNA and the notion of correlation of leukocyte telomere length 
attrition across tissue types (155) make leukocytes attractive cells for 
measuring telomere length. Since the first telomere measurement in the year 
1988 utilizing DNA sequencing (156), many methods have been introduced 
(157).
Terminal restriction fragment (TRF) analysis utilizes ‘TTAGGG’-labelled 
probes in detecting telomeric regions, which can be run through gel 
electrophoresis and Southern blot analysis (158,159). TRF analysis gives 
average LTL’s in kilobases. However, large amounts of DNA are required and 
performing of the assays can be time consuming and moreover, inclusion of 
other areas than the actual telomeres, or the use of enzymes, may affect 
measurement results.
The polymerase chain reaction (PCR) method is widely used in 
epidemiological studies due to its high throughput, low requirement of sample 
DNA and low cost. The method measures the proportion of telomere signals 
(T) to a single-copy gene signal (S) that acts as a reference, giving relative 
measures of telomere length, as T/S-ratios rather than absolute telomere 
length in kilobases (160,161). Drawbacks of the PCR method include higher 
coefficients of variation than with the TRF method and inability to capture 
lengths of the shortest telomeres (157).
As a surrogate marker of cellular lifespan, short LTL has been shown to be 
associated with a range of clinical conditions, presented in Table 3. Mutations 
in areas that normally generate functioning telomere complexes may result in 
pathologic disease states including bone marrow failure, dyskeratosis 
congenita, acquired aplastic anemia and pulmonary fibrosis (162).
The role of short LTL in chronic disease pathogenesis has been studied 
extensively. Short LTL has been associated with increased thickness of the 
intima of the carotid artery (163), carotid atherosclerosis (164) and CAD
(165,166). Among individuals with established CAD, short LTL was associated 
with better responsiveness to conventional statin treatment than did longer 
LTL (165). Short LTL has been associated with premature myocardial 
infarction (167) and mortality among patients with CAD (168) whereas no 
association between LTL and incident atrial fibrillation has been observed
(169).
Compared to controls with normal glucose regulation, shorter LTL has 
been observed among those with IGT (170) and type 2 diabetes (171,172). Short 
LTL has also been linked with incident type 2 diabetes in some (173,174) but 
not all studies (175). Similarly, short LTL has been associated with a higher
body fat percentage and subcutaneous fat but not with other related measures 
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of body composition including the amount of visceral fat and overall BMI
(176).
Telomere biology has been suggested to play an important role in the 
development of some cancers (162). Meta-analyses of observational studies 
suggest an increased overall cancer risk among individuals with short LTL and 
that this risk would further be elevated in certain types of cancers including 
those of the bladder, lung and digestive system (177,178). However, an 
association between long LTL and melanoma risk has also been reported (179).
Besides cellular lifespan, LTL has also been linked with the human lifespan 
showing an increased all-cause mortality risk among individuals with short 
LTL (180,181). This association has been shown to vary according to ethnicity
(182). However, some studies report no association between LTL and 
mortality (183).












Note. 1(165), 2(166), 3(173), 4(174), 5(167), 6(184), 7(185), 8(186), 9(187), 10(188), 
11(189), 12(190), 13(191), 14(192), 15(193), 16(177), 17(178)
Evidence on the associations between LTL and frailty criteria is not consistent. 
In a study of older twins, individuals in the category with the highest LTPA 
had on average longer LTL compared to those in the category with the lowest 
LTPA, and among twins, the more active twin often had longer LTL than the 
less active twin (194). Among older African American and white women,
women exceeding the recommendation of LTPA had significantly longer LTL 
than women who were the least active (195). In a study of older business 
executives, moderate LTPA was associated with long LTL at the follow-up, and 
LTLs of groups with either high or low LTPA had on average shorter LTL than 
that observed for those in the moderate LTPA group (196).
Evidence from cross-sectional studies suggest an association between
longer LTL and better grip strength among older individuals (197) and that 
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this association may vary by sex (198). However, grip strength at the mean age 
of 31 years was not associated with LTL (199). When it comes to walking speed, 
most (197,198) but not all (200) studies found no association between LTL and 
walking speed. No studies assessing associations between weight loss, 
exhaustion and LTL were identified.
Studies investigating the association between LTL and frailty have 
provided contradictory results. In studies defining frailty according to the 
criteria put forward by Fried (201–203), Rockwood (204–206) or both 
(207,208), no associations between LTL and frailty were observed. On the 
other hand, an increasing body of literature also suggests the opposite; short
LTL was associated with frailty according to Fried (209) and with a definition 
of frailty composed of information from laboratory measurements only (210).
Studies of telomere shortening and adult health involve longitudinal study 
settings where several LTL measurements are available for individual 
participants. In a recent study of men and women aged 31-76 years, telomere 
shortening was not associated with carotid atherosclerosis during a 9.5-year 
follow-up (164). Among patients with heart failure, telomere shortening was 
not associated with incident mortality or hospitalization due to heart failure
(211). When telomere shortening and the metabolic syndrome were studied, 
no associations were observed; however, a greater increase in waist 
circumference was associated with accelerated telomere shortening (212).
Similarly, weak associations between increases in waist circumference and 
accelerated telomere shortening were observed (213). Furthermore, an 
association between shortening of telomeres in pancreatic -cells during a 10-
year follow-up and diabetes has been reported (214).
Telomere shortening may not be involved in the disease progression of 
obstructive pulmonary disease, depression and anxiety disorders (215–217). 
However, greater telomere attrition has been associated with changes to the 
central nervous system, namely the loss of hippocampal volume and changes 
to the fornix (218). Telomere shortening during a 13-year follow-up period was 
observed to be associated with poorer global cognition in individuals aged 48-
52 years (219). In a study of 1,356 individuals aged 30-70 years, telomere 
shortening was not associated with all-cause mortality over 10 years of follow-
up (220).
Currently there are no available studies that report associations between LTL 
shortening and frailty. In the Hertfordshire cohort, telomere shortening and 
grip strength, which is used in determining the frailty criterion of weakness,
were studied across 10 years of follow-up. An association between greater 
telomere shortening and decreased grip strength at the follow-up was 
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observed, however, these results were attenuated after controlling for 
inflammatory markers. In that study, measurements related to determining 
the criteria of slowness (walking speed from a 6-minute walking test) and low 
physical activity (LTPA, self-reported physical performance) were also 
available, showing no associations between the 6-minute walking test, self-
reported physical performance and telomere shortening. (221)
Telomere shortening was not associated with walking speed or grip 
strength in adults aged 53-80 years with a follow-up ranging from 7.5 to 10.2
years (197). In two subsets of the Lothnian birth cohort, changes in telomere 
length were not associated with changes in walking speed (6-minute walking 
test) and grip strength (222). No studies assessing telomere shortening and 
the criteria of weight loss and exhaustion were identified.
Frailty is a geriatric syndrome that is characterized by the loss of biological 
reserve and resistance to stressors across several organ systems due to 
accelerated and cumulative ageing-associated decline which results in 
vulnerability to minor changes in health status (2,4). Frail individuals who face 
stressors recover slower than non-frail peers, and under some circumstances, 
previous homeostatic levels may not be achieved due to incomplete recovery 
(3). After the introduction of frailty in the 1980s (223), many definitions of 
frailty have been introduced (224).
Frailty was defined as a clinical syndrome that comprised of five criteria: 
unintentional weight loss, self-reported exhaustion, weakness, slowness and 
low physical activity (Table 4). When a critical threshold of three or more of 
these criteria was present, the person was considered frail and those with one 
or two criteria were defined as pre-frail. Frailty has been suggested to overlap
in part with burden from other chronic diseases (defined as 2 or more), i.e. 
comorbidity, and disability in activities of daily living (ADL) (defined as 
disability in 1 or more ADLs).
In the Cardiovascular Health Study, two prospective cohorts including 
5,317 men and women aged 65 years and older were first evaluated at baseline 
and then followed up annually for a maximal period of 7 years. Those with 
Parkinson’s disease, stroke, Mini-Mental scores of less than 18 and those using 
certain medications were excluded. At baseline, 7 % of the cohort was
considered frail and 3 to 4-year frailty incidences ranged from 7 to 11 %. Those 
who fulfilled at least one criterion but not as many as three or more were 
considered pre-frail (47 % at baseline) and those who fulfilled none were 
considered not to be frail (46 % at baseline). (2)
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Associations between baseline frailty classification and incident adverse 
health outcomes were assessed: frail individuals had significantly greater 
mortality rates at the 3-year (18 and 3 %) and 7-year (43 and 12 %) follow-ups 
compared to individuals who were not frail. Associations between frailty and 
incident hospitalization, falls and worsening disability were also observed
after adjustment for covariates (including age, gender, indicator for minority 
cohort, income, smoking status, brachial and tibial blood pressure, fasting 
glucose, albumin, creatinine, carotid stenosis, history of congestive heart 
failure, cognitive function, major electrocardiograph abnormality, use of 
diuretics, promlem with IADLs, self-report health measures and a modified 
depression measure), showing a step-wise increase with increasing frailty 
status. (2)
Frailty phenotypea model criteria and measures
Criterion Measure
Weight loss Self-reported unintentional weight loss of 
4.5 kg or greater or 5% of body weight per 
year
Exhaustion Self-reported exhaustion on three days or 
more per week using the US Centre for 
Epidemiological Studies depression scaleb
Weakness Grip strength, sex- and BMI-stratified; 
lowest quintile (20 %)
Slowness Walking speed on a 4.57 m distance, sex- and 
height-stratified; lowest quintile (20 %)
Physical activity Energy expenditures of <383 Kcal (men) and 
<270 Kcal (women) calculated from a LTPA 
questionnairec
Note. a(2), b(225), c(226).
The cumulative deficit model identifies frailty as the proportion of 
accumulated deficits, which can be symptoms, signs, functional impairments 
and laboratory abnormalities. Based on these deficits an index score can be 
calculated, representing the number of deficits proportional to the total 
number of deficits in the model. For example, out of 48 deficits, those scoring 
12 deficits would have a frailty index score of 0.25. All deficits are weighed 
equally, and a minimum of 30 deficits should be included for the model to be 
valid. (227,228)
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Evidence indicates that the mean prevalence of frailty among community-
dwelling individuals aged 65 years and older varies greatly, from 4.0 to 59.1 %, 
with a weighted mean prevalence of 10.7 % according to different methods of 
defining frailty (229). In nursing home settings, even greater variability has 
been observed, with prevalence estimates ranging from 19.0 to 75.6 % (230).
Much of this variance can be attributed to differences in chronological age. 
Among 65 to 69 year-olds, an estimated 5 % of individuals were classified as 
frail as opposed to those aged 85 years and older, where estimates ranged from 
20 % upwards to 50 % (229). 
Besides age, gender and the used frailty definition may give slightly 
different prevalence estimates. In a systematic review, use of either the frailty 
phenotype or cumulative deficit models resulted in weighted prevalence 
estimates of 9.9 % (95 % CI 9.6-10.2; 15 studies and 44,894 participants) and 
13.6 % (95 % CI 13.2-14.0; 8 studies and 24,072 participants), respectively 
(229). The prevalence of frailty was higher among women (9.6 %) than men 
(5.2 %) irrespective of the used frailty definition (229).
Evidence from meta-analyses of observational studies on the association 
between frailty and adverse health outcomes is presented in Table 5. Studies
suggest that frailty has a moderate to substantial association with later risk of 
falls, fractures, hospitalization, dementia, nursing home admission, disability 
and mortality (5–10,231,232). The association between mortality and frailty 
has further been replicated in recent meta-analyses to include several other 
frailty definitions (233,234).
Frailty and adverse health outcomes, evidence from meta-analyses of 
observational studies.




Fallsa 68,723 OR 1.84 (1.43-2.38) 1.25 (1.01-1.53)
Fracturesb 96,564 OR 1.70 (1.34-2.15) 1.32 (1.18-1.46)
Hospitalizationc 74,900 OR 1.90 (1.74-2.07) 1.13 (1.04-1.24)
Dementiad 10,680 HR 1.33 (1.07-1.67)
Nursing home 
admissione









35,538 HR 2.00 (1.73-2.32) 1.33 (1.26-1.42)
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Note. ADL=activities of daily living, IADL=instrumental activities in daily 
living, OR=odds ratio, HR=hazard ratio. a(10), b(9), c(8), d(231), e(6), f(7), 
g(5).
Multiple frailty determinants have been identified across several areas and 
stages of life. Frail individuals are more commonly older, female, obese, and 
report difficulties with their personal finances as well as decreased health and 
cognition, shown in Table 6.
Early life predictors of frailty have been less studied. In a study that 
included five cities in Latin America, poor childhood economic situation, 
health and experiences of hunger were found to be associated with frailty in 
individuals aged 60 years and older (235). In another study, despite being 
associated with frailty in some analyses, childhood living conditions were not 
associated with frailty after adjusting for covariates (including age, gender, 
marital status, cigarette smoking and alcohol consumption) (236). In the 
Lothnian Birth Cohort, lower intelligence at 11 years of age and a lower 
childhood socioeconomic status (SES) were associated with frailty decades 
later, whereas childhood home environmental deprivation was not (237).




Lower income1,2,3,5, lower educational level1,2,3,5
Physical
Obesity (BMI 30)2,3,5
Higher number of ADL problems4
Reduced extremity function4
Biological
Individual chronic diseases1,2,3, total number of chronic diseases1,2
Polypharmacy11
High C-reactive protein5,7,8, Elevated markers of blood clotting9




Alcohol consumption (no/past drinker)2, (no/high consumption)12






Note. 1(2), 2(12), 3(238), 4 (13), 5(239), 6(240), 7(241), 8(242), 9(243), 10(244), 
11(14), 12(245)
Inflammation is a key host defence mechanism against microbial invasion, but 
purposeless activation of the innate immune signaling and related 
mechanisms may lead to prolonged inflammation without microbes, and 
again, increased circulating levels of proinflammatory cytokines including
interleukin 1 (IL-1), interleukin 6 (IL-6), tumor necrosis factor alpha (TNF-
and interferon gamma (INF- and proteins as C-reactive protein (CRP)
(246,247). Levels of these circulating cytokines may be further exacerbated by 
oxidative stress, accumulation of advanced glycation end-products, 
mitochondrial dysfunction, proinflammatory lipid signaling, cell senescence 
and epigenetic mechanisms (248).
Increased levels of inflammatory cytokines may have harmful effects on 
tissues and organs that lie on the pathway to frailty. In muscle tissue, increased 
levels of proinflammatory cytokines (Il-1, IL-6 and TNF- ) may reduce the 
viability of the tissue through 1) reduced IGF-mediated metabolism, 2) 
dysfunction of blood vessels and blood supply and 3) through impairing the 
regenerative effects of satellite cells on muscle tissue (249). Sarcopenia, which 
refers to ageing-related loss of skeletal muscle mass, lies on the central 
pathway to frailty (250,251).
It has been suggested that frailty would share similar pathology to delirium 
and cognitive decline (3). The presence of an inflammatory trigger may result 
in the activation of proinflammatory cytokines and inflammatory mediators in 
the central nervous system, that would trough neural or humoral mechanisms,
trigger activation of microglial cells, which are resident macrophages of the 
central nervous system. Another mechanism involves the production of 
reactive oxygen and nitrogen species, which in turn, may enhance 
inflammatory responses. (252)
The endocrine mechanisms predisposing to frailty may involve 
dysregulations in cortisol, growth hormone and androgen metabolism. 
Dysregulation and abnormal sensitivity to inflammatory stimuli in the HPA-
axis may lead to chronically elevated cortisol levels and muscle atrophy. 
Decreased secretion of growth hormone and production of IGFs may alter 
body composition by increasing the proportion of fat and decreasing the 
proportion of lean mass. Moreover, lower circulating levels of testosterone and 
vitamin D have been reported among frail individuals. (253)
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Randomized controlled trials (RCTs) aimed at reducing frailty have included 
interventions that involved physical activity, nutritional counselling and 
memory training. In studies where physical activity interventions with 
durations ranging from 3 to 12 months were used, reductions in the mean 
numbers of respective frailty criteria (254–256) as well as frailty prevalence
(257) have been observed. Similarly, in studies where combined physical 
activity and nutritional interventions were used, decreases in the prevalence 
of frailty (258–260) and its criteria (261) were observed. In a study where 
nutritional, cognitive and physical interventions were applied, combination 
interventions resulted in the greatest reductions in mean frailty scores 
compared to the control group (262).
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The aim of this study was to explore frailty from a life-course perspective by 
investigating associations between factors taking place during gestation, 
childhood, adulthood and old age and frailty.
The specific aims of the study were as follows:
1. To explore the association of maternal BMI, birth order or their new 
borns and body sizes at birth, childhood socioeconomic status, and 
frailty in old age (I).
2. To determine the relationship between infant and childhood growth 
and susceptibility to frailty in old age (II).
3. To study the association between wartime separation from both 
parents, a severe form of ELS, and frailty in old age (III).
4. To explore prospective associations between LTL at 61y and frailty at 
71y, cross-sectional associations between LTL and frailty at 71y and the 




Helsinki Birth Cohort Study is a longitudinal birth cohort that includes more 
than 20,000 individuals born in Helsinki between the years 1924-1933 and 
1934-1944. The younger cohort consists of 13,345 individuals who were born 
either in Helsinki University Central Hospital (HUCH) or Helsinki City 
Maternity Hospital, between 1934 and 1944. This thesis focuses on the 8,760 
participants, 4,630 men and 4,130 women, who were born in HUCH.
All participants visited child welfare clinics in the city of Helsinki where a 
majority also went to school. The assignment of a unique personal
identification number to all Finnish residents in 1971 enabled tracing of the 
study participants and their inclusion in the study. In the year 2000, 7,079 
individuals born in HUCH were traced and sent a questionnaire which was 
modified from those used previously in the Health 2000 and FINRISK studies
(263). The questionnaire, which was filled in by 4,595 participants, included 
questions on e.g. the respondents’ overall health status, use of medication, 
lifestyle and socioeconomic circumstances. 
Of the 4,595 individuals who completed the questionnaire, a sample of 
2,902 individuals was drawn using random number tables and was invited to 
take part in a clinical study. 2,003 cohort members participated in the baseline 
clinical examination which took place between 2001 and 2004. Of the 2,003 
individuals who were examined clinically, 151 had died, 212 had declined 
further participation in the study and 236 lived further than within a 100-
kilometer distance from Helsinki at the time of the follow-up clinical
examination between 2011 and 2013. As a result, 1,404 participants were 
invited and of which 1,094 participated in the follow-up clinical examination. 
These 1,094 participants formed the analytical sample of the present study, 
illustrated in Figure 3.
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Data on maternal weight, height, last menstrual period and parity had been 
recorded upon admission to hospital in labor and were later extracted from 
hospital birth records, which had been stored in the Helsinki City archives.
Information of their newly born babies, extracted from hospital birth records, 
included measurements of birth weight and birth length. BMI at birth was 
calculated as weight in kilograms divided by square of length in meters 
(kg/m2).
Records held at child welfare clinics and school healthcare facilities provided 
information on the serial measurements of the participants’ weight and height 
in infancy and childhood. On average, 17 measurements of size including 
height and weight were available for each participant from birth to 11 years of 
age. Besides measurements of size, information on childhood SES was 
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extracted from these records, which had been stored in the Helsinki City 
archives. Childhood SES was determined using information on the father’s 
highest occupation and classified as manual workers, lower middle class and 
upper middle class according to the classification system by Statistics Finland
(264).
Approximately 70,000 Finnish children from various backgrounds were 
evacuated abroad unaccompanied by their parents during WWII. The children 
were sent to foster care primarily to Sweden, but also to Denmark, through
Government-aided programs and personal relations. While factors as shelter 
from bombardments and food shortages may have influenced participation in 
these voluntary evacuations, the effects of various political and family-related 
factors cannot be excluded (125,265).
The evacuated children were separated from their new foster families and 
sent back to their original families after the war was over. Because Finland 
fought two wars during WWII, some children may have experienced 
separation from their original families more than once.
Registers held at the Finnish National Archives provide documentation of 
the 48,628 children who were sent abroad through the Finnish Government.
Information on the age at and duration of the separation was extracted from 
these registers. To identify the children who had been evacuated through
personal relations and thus were not included in the registers held by the 
Government, self-reported information on wartime evacuations was gathered 
using questionnaires at the baseline clinical examination between the years 
2001 and 2004.
The present study included 117 (12.0 %) war evacuees. Register information 
on duration of and age at evacuation was available for 99 and 101 participants, 
respectively. The age at evacuation was categorized into two groups (under the 
age of 4 or 4 years and older) based on the cohort median, which was 3.62 
years. The duration of the separation was divided into three groups (under 1 
year, from 1 year to 2 years, more than 2 years) in accordance with previous 
publications (141,266). Self-reported evacuation data were available for 16
participants. Of the original cohort of 1,078, separation status was missing for 
106 participants, resulting in a sample of 972 individuals with data on both 
wartime separation status and frailty.
The baseline clinical examination included 2,003 individuals and was carried 
out in 2001-2004. The participants had fasted overnight before attending the 
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examination. Written informed consent was obtained from each participant 
prior to the measurements carried out by trained study nurses.
Anthropometric measurements including weight in light indoor clothing 
without shoes rounded to the nearest 0.1 kg and height rounded to the nearest 
0.1 cm were measured together with an estimate of body composition. Waist 
circumference was measured at midpoint between the iliac crest and the 
lowest rib. Body fat percentage was assessed using the InBody 3.0 eight-polar 
tactile electrode system (Biospace Co. Ltd, Seoul, Korea). Segmental 
multifrequency analyses (5, 50, 250 and 500 kHz) were performed for trunk 
and each limb. The method has been found to give accurate estimates of body 
composition (267,268).
Standard laboratory testing including assessment of fasting plasma 
glucose, blood lipoproteins, markers of inflammation and adipocytokines was
performed. Furthermore, each participant underwent a 2-hour 75 g oral 
glucose tolerance test. Blood pressure was measured in a sitting position as the 
mean of two consecutive measurements from the right arm using a standard 
sphygmomanometer.
Self-administered questionnaires provided information on chronic 
physician-diagnosed diseases (e.g. hypertension, CVD and type 2 diabetes) 
and lifestyle-related behaviors including smoking habits (coded as current 
smoker , former smoker, never smoked) and physical 
activity (coded as sedentary, brisk walking or comparable activity 2 times a 
week at most or 3 or more times per week).
Adult SES was defined using information on occupational status from 
Statistics Finland. Information on maximal occupational status attained at 5-
year intervals between the years 1970 and 2000 was used to group the 
participants into manual workers, self-employed, lower middle class and 
upper middle class. 
Frailty was assessed at the follow-up clinical examination between the years 
2011 and 2013 using the phenotype definition put forward by Fried (2). This 
validated method for assessing frailty consists of five criteria that include 
weight loss, exhaustion, low physical activity, slowness and weakness.
Weight loss was assessed using a question from the Beck Depression 
Inventory (BDI) (269), and those who reported losing 5 kg or more recently, 
met the criterion. The following question was used to evaluate weakness: “How 
many times during the last week have you felt unusually tired or weak?” The 
criterion was met if the response was “On three days or more”. The validated 
Kuopio Ischemic Heart Disease Risk Study (KIHD) questionnaire (270) was 
used to assess LTPA. The criterion of low physical activity was met if the 
participant’s total LTPA time (including e.g. walking, resistance training and 
gardening) was 1 hour or less per week. In case of missing KIHD LTPA data, 
as was the case with 42 individuals, low physical activity was evaluated using 
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the following question: “In total, how many hours per week do you do the 
following sports (including e.g. walking, jogging, cycling, swimming, 
gymnastics and group exercise)?” Those who reported their total duration of 
physical activity as 1 hour per week at most met the criterion.
Objective measurements of walking speed and grip strength were used to 
assess the criteria of slowness and weakness, respectively. The criterion of 
slowness was evaluated by measuring maximal walking speed over a 4.57-
meter distance. Sex-specific cut-offs for medium height ( cm
cut-
cut-off was 1.47 m/sec and >162.2 cm 1.55 m/sec) were used to identify the 
slowest 20 % that met the criterion. For weakness, grip strength of the 
dominant hand was measured using an adjustable dynamometer chair (Good 
Strength, Metitur Ltd, Jyväskylä, Finland), and for the assessment of the 
criterion, sex-specific quartiles of BMI were used to identify the 20 % with the 
lowest grip strength score.
The participants were classified as either frail (those fulfilling three or more 
criteria), pre-frail (those fulfilling one or two criteria) or non-frail (those 
fulfilling no criteria).
LTL was measured at the baseline clinical examination in 2001-2004 and at 
the follow-up clinical examination after a 10-year period between 2011 and 
2013. Commercially available kits (QIAamp blood Maxi kit and DNeasy blood 
and tissue kit, Qiagen s.r.l. [Venlo, The Netherlands]) were used according to 
the manufacturer’s instruction to extract DNA from peripheral whole blood. 
DNA contamination for salts and other contaminants was assessed by 
comparing ultraviolet absorbance at wavelengths of 260 nm to absorbance at 
230 nm (260/230 ratio) and to 280 nm (260/280 ratio), respectively. Samples 
with ratios ranging between 1.7 and 2.1 were considered pure and could hence 
be studied further. DNA integrity was assessed by electrophoresis in 0.8 %
agarose/0.5x TBE with 0.1 l/ml ethidium bromide at 100 V for 15 to 25 
minutes.
Using slightly different methodology, a real time quantitative PCR 
approach was applied at both time points to measure relative LTL. First in 
2001-2004, LTL was determined as the ratio of telomere DNA to hemoglobin 
beta single-copy gene signal intensities, as described previously (160,271). In 
brief, based on the method described by O’Callaghan (272), reaction-specific 
standard curves were created by including a synthetic oligomer Sigma (St 
Louis, Missouri, USA) dilution series, hbg-120-mer and tel14x in each plate. 
Furthermore, a constant 10 ng of total DNA per reaction was maintained by 
adding plasmid DNA (pcDNA3.1) to each standard. Quality control was carried 
out using the Bio-Rad CFX Manager software v.1.6 9 (Bio-Rad Laboratories, 
Hercules, CA, USA). Four genomic DNA control samples were included in all 
plates for calibration of the plate effect and further, to monitor the coefficient 
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of variation (CV), which was 21.0 % for the telomere reaction, 6.0 % for the -
hemoglobin reaction, and 24.8 % for their ratio (T/S). Telomere and reference 
gene signals were normalized to the corresponding mean of four control 
samples that were analyzed for each qPCR plate before taking the T/S ratio to 
account for the plate effect.
Later in 2011-2013, LTL was measured using a multiplex quantitative real-
time PCR method, described previously by Cawthon and with minimum 
modifications (161). In brief, a standardized DNA concentration of 4 ng/ was 
combined with telomere primers pair 900 nM, beta globin (as single-copy 
gene) primers pair 500 nM, and 2X master mix (IQ Sybr green supermix, Bio-
Rad Laboratories). PCR reactions using the original thermal cycle (161) set up 
in a 384-well plate (CFX384 Touch Real-Time PCR detection system, Bio-Rad 
Laboratories) were carried out in a final volume of 10 l. A 1:3 serial dilution 
curve was run for assessment of the efficiency of the amplification. A dedicated 
software (CFX Manager Software, Bio-Rad Laboratories) was used to analyse
threshold cycles for both beta-globin and telomere amplification. The ratio 
between the amplification of the telomere sequence (T) and that of a single 
copy gene (S), expressed as a relative telomere length (T/S), was measured for 
each sample in the same well and PCR run, and additionally, normalized by 
the use of a common reference DNA sample. Samples were run in triplicate; 
the mean coefficient of variation of each triplicate was 6.0%, and the mean 
inter-assay CV% was 6.2%.
Information on LTL was available for 1,042 and 1,061 participants, 
respectively at the baseline and follow-up clinical examinations. 1,037 
individuals had their measurements taken on both time points. Telomere 
shortening during the 10-year period was calculated adjusting for the baseline 
relative LTL measurement (relative change in LTL = {[LTL at 71] – [LTL at 
61]} / [LTL at 61] × 100) to avoid error due to different methodology used.
The baseline characteristics from studies I-IV were expressed as means and 
standard deviations (SD) in case of continuous and as proportions for 
dichotomous or categorical variables. Differences between groups were 
assessed using Students t-test or one-way ANOVA and Pearson’s chi-squared 
test, respectively for normally distributed continuous and categorical values. 
Interaction terms were created to test whether associations between predictor
and outcome variables were depended on other predictor variables. If a
statistically significant (p<0.05) sex x predictor interaction on the outcome 
was observed, the analyses were presented separately for men and women.
In study I, multinomial regression analyses were used to study associations 
between early life determinants (including birth weight, birth length, birth 
BMI, parity and mother’s BMI) and frailty in old age. Furthermore, the 
associations between childhood and adult SES and frailty were studied. While 
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no interactions between sex and early determinants on frailty were observed, 
the results were pooled by sex. The models were first adjusted for sex and age. 
Further adjustments were made for covariates including gestational age, 
childhood and adulthood SES, BMI in adulthood, smoking, hypertension and 
diabetes. Because of missing covariate data (maximum proportion of data 
missing was 3.1 %), multiple imputations were used to obtain a complete 
dataset. Altogether 20 imputed datasets were generated using information 
from all variables that were included in the analyses. The analyses were first 
performed using complete data available for all main variables and covariates 
and then using the imputed datasets combining the effect estimates using 
Rubin’s rules. While these results were very similar, findings on imputed data 
were presented.
In study II, associations between serial measurements of growth and frailty 
were studied using multinomial regression analyses. To achieve this, 
measurements of size for each individual, ranging from birth to 11 years of age, 
were converted into z scores that represent the difference from the cohort 
mean and are expressed as standard deviations (273). By using previous 
growth measurements as a predictor of future size, differences between 
predicted and measured size at each age were examined using the residuals 
from linear regression, referred to as conditional growth. Conditional growth 
was calculated for the age periods of 0-6 months, 6-24 months and 2-11 years. 
Conditional BMI gain was analysed separately for men and women because of 
an interaction between sex and conditional BMI gain for 2-11 years on frailty. 
The analyses were first adjusted for age and sex without the exception of 
conditional BMI gain where analyses were performed separately for men and 
women. The analyses were then adjusted further for childhood and adult SES, 
BMI in adulthood, smoking, hypertension and diabetes.
Additionally, in study II, associations between individual measurements of 
size including height, weight and BMI and frailty were examined. The 
associations between weight, height and BMI measured at birth and at 1, 2, 7 
and 11 years of age and frailty were studied using multinomial regression 
analyses. The combined associations of size at birth and that measured at 11 
years and frailty were assessed by first dividing the participants into three 
groups according to their birth weight and BMI at 11 years and second, by
observing differences in the prevalence of frailty between the groups. Age at 
BMI rebound, a point in time at which body fatness normally decreases to 
minimum before increasing into adolescence (94), was estimated by 
calculating age at minimum BMI between the ages from 1 to 12 years. The 
models were first adjusted for age and sex, and additionally for covariates as 
listed previously for study II, since no interactions between sex and the 
covariates on frailty were observed.
In study III, a multinomial regression analysis was conducted to study 
associations between wartime separation (indicating ELS) and frailty. 
Additional binomial logistic regression analyses were performed to assess 
associations between wartime separation and frailty criteria. Although no 
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interactions between sex and wartime separation status on frailty were 
observed, the analyses were performed separately for men and women due to 
previous findings on sex differences in the association between ELS and later 
health outcomes (266). The results were first adjusted for age and then 
additionally for covariates including birth weight, childhood and adult SES, 
smoking, hypertension and diabetes. As in study I, a complete dataset on 
covariates was acquired by multiple imputation (maximum proportion of data 
missing was 1.1 %), and while the results were very similar, findings are 
presented based on imputed data.
In study IV, the association of LTL and the rate of telomere shortening 
during a 10-year period and frailty were studied using multinomial regression 
analyses. No significant interactions between sex and telomere length on 
frailty were observed. The analyses were first adjusted for age and sex, and 
furthermore for adult SES, adult body fat percentage, smoking and the 
presence of CVD and diabetes.
In studies I-IV, additional binomial regression analyses were performed to 
determine whether any of the individual frailty criteria were driving the 
association between early life predictor variables and frailty. Without the 
exception of study IV where significant (p<0.05) interactions between sex and 
telomere measurements on slowness were observed, the results were reported 
pooled by sex. All analyses were performed two-tailed, the level of significance 
was set at p<0.05. Analyses were carried out using SPSS (IBM SPSS Statistics 
for Windows, Version 23.0 IBM Corp. Released 2015, Armonk, NY).
The present study complies with the guidelines of the Declaration of Helsinki. 
The Coordinating Ethics Committee of the Hospital District of Helsinki and 
Uusimaa and the ethical committee at the National Public Health Institute 
have approved of the clinical study protocol. Written informed consent was 
obtained from each participant before initiating any study procedures.
Results
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Characteristics of the 1,078 individuals, 475 men and 603 women, are 
summarized in Table 7. While the majority of the participants came from a 
background of manual workers, upward social mobility was observed 
particularly among women, who later in their adult lives were most often 
classified as representatives of the lower middle class. At the time of the 
baseline clinical examination between the years 2001-2004, men were more 
often current smokers and had diabetes (p- than women.
Frailty, which was assessed at the time of the follow-up clinical 
examination in 2011-2013, was more prevalent among women (4.3%) than 
men (2.7%) at the average ages of 71.1 (SD 2.6) and 70.8 years (SD 2.8), 
respectively. Although no significant sex difference in frailty was found, the 
criteria of exhaustion (9.6% and 5.1%) and low physical activity (11.6% and 
7.4%) were more commonly met among women than men (p-
Characteristics of the study population.








Childhood SES 1074 0.072
Upper middle class (%) 19.5 22.3 17.2
Lower middle class (%) 41.9 22.7 22.2
Manual workers (%) 58.1 54.7 60.4
Adult SES 1078 <0.001
Upper middle class (%) 16.8 23.6 11.4
Lower middle class (%) 46.0 28.0 60.2
Self-employed (%) 8.5 9.3 8.0
Manual workers (%) 28.7 39.2 20.4
Characteristics in late adulthood (mean age 61 years)
BMI (kg/m2) 1066 27.0 (4.5) 468 26.8 (3.8) 598 27.3 (5.0) 0.439
Body fat (%) 1039 28.7 (8.0) 454 22.9 (5.5) 585 33.2 (6.6) <0.001
Current smoker (%) 1071 19.1 471 20.8 600 17.8 <0.001
Hypertension (%)b 1075 31.8 473 32.1 602 31.6 0.841
Cardiovascular disease 
(%)b
1075 5.6 473 4.7 602 6.3 0.239
Diabetes (%)b 1075 5.2 473 6.8 602 4.0 0.042
Characteristics in old age (mean age 71 years)
Frailty classification 1078 0.383
Non-frail (%) 56.4 56.6 56.2
Pre-frail (%) 40.0 40.6 39.5
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Frail (%) 39 3.6 13 2.7 26 4.3
Frailty criteria
Weight loss (%) 5.7 6.5 5.1 0.361
Exhaustion (%) 7.6 5.1 9.6 0.005
Low physical activity (%) 9.7 7.4 11.6 0.020
Slowness (%) 19.8 20.2 19.9 0.910
Weakness (%) 19.9 19.7 20.1 0.858
Note. SD=standard deviation, SES=socioeconomic status, BMI=body mass index. a Difference 
between men and women. b Self-reported.
A graded increase in the prevalence of comorbidities including reported CVD, 
diabetes and hypertension was observed among the non-frail, pre-frail and 
frail participants, illustrated in Figure 4. Furthermore, the percentage of 
individuals with a manual working family background (ptrend=0.118) as well as 
the percentage of individuals who were classified as manual workers in 
adulthood (ptrend=0.001) increased at the expense of other socioeconomic 
groups with progressing frailty classification (Figure 5). Similarly, those who 
were classified as frail at the mean age of 71 years, had had greater BMI and 




The newborn weighed on average 3.42 kg (SD 0.46) and were 50.4 cm (SD 1.9) 
long, with the baby boys being slightly bigger at birth than their female 
counterparts (p-values <0.001, Table 8). Their mothers, who carried the
babies for a mean duration of 39.4 weeks (SD 1.8), had an average BMI of 26.5 
kg/m2 (SD 2.8) before admission on labour. Primipara women, who 
constituted 45.9% of the participants’ mothers, gave birth to boys slightly more 
often than girls, and reversely, to girls more often than boys if the mother had 
previously been admitted to labour (ptrend=0.012).
Early life characteristics of the participants.








Birth weight (kg) 1078 3.42 (0.46) 475 3.48 (0.49) 603 3.36 (0.44) <0.001
Birth length (cm) 1066 50.4 (1.9) 469 50.7 (2.0) 597 50.1 (1.8) <0.001
Birth BMI (kg/m2) 1066 13.4 (1.2) 469 13.5 (1.3) 597 13.4 (1.2) 0.145
Gestational age (weeks) 1045 39.4 (1.8) 464 39.3 (1.8) 581 39.4 (1.8) 0.301
Mother’s BMI (kg/m2) 935 26.5 (2.8) 410 26.6 (2.9) 525 26.5 (2.8) 0.228
Parity 1078 0.012
First born (%) 45.9 46.1 45.8
Second born or later (%) 54.1 53.9 54.2
Note. SD=standard deviation, BMI=body mass index. a Difference between men and women.
An inverse association was observed between different measures of body size 
at birth and frailty, shown in Table 9. The relative risk ratio (RRR) of frailty 
compared to non-frail individuals was decreased by 60% per each 1 kg increase 
in birth weight (RRR 0.40, 95% CI 0.19, 0.82, p=0.012), adjusted for age and 
sex. A similar association was observed for each 1 cm increase in birth length 
(RRR 0.78, 95% CI 0.66, 0.91, p=0.002). A one unit increase in birth BMI, in 
which the effects of birth weight and length are combined, corresponded to a
significantly decreased RRR of frailty (RRR 0.03, 95% CI 0.003, 0.25, 
p=0.002) compared to the non-frail, in analyses adjusted for age and sex. All 
associations persisted after further adjustment for gestational age, childhood 
and adult SES, adult BMI, smoking behaviour, hypertension and diabetes. The 
RRR’s of frailty were 0.36 (95% CI 0.15, 0.85, p=0.020), 0.78 (95% CI 0.64, 
0.95, p=0.012) and 0.02 (95% CI 0.001, 0.73, p=0.033), respectively for one-
unit increase in birth weight, length and BMI in the fully adjusted analyses. No 




Relative risk ratios of frailty and pre-frailty per one-unit increase (kg, cm, or kg/m2)
in early life characteristics compared to the non-frail individuals for men and 
women combined.
Model 1a Model 2b Model 3c
RRR (95% CI) p RRR (95% CI) p RRR (95% CI) p
Birth weight
Non-frail ref. ref. ref.
Pre-frail 0.73 (0.56, 0.96) 0.023 0.77 (0.57, 1.04) 0.093 0.73 (0.53, 0.99) 0.044
Frail 0.40 (0.19, 0.82) 0.012 0.36 (0.16, 0.80) 0.012 0.36 (0.15, 0.85) 0.020
Birth length
Non-frail ref. ref. ref.
Pre-frail 0.92 (0.86, 0.98) 0.014 0.93 (0.86, 1.00) 0.049 0.92 (0.85, 0.99) 0.031
Frail 0.78 (0.66, 0.91) 0.002 0.76 (0.63, 0.91) 0.003 0.78 (0.64, 0.95) 0.012
Birth BMId
Non-frail ref. ref. ref.
Pre-frail 0.43 (0.08, 2.28) 0.322 0.55 (0.10, 3.00) 0.488 0.52 (0.08, 3.25) 0.519
Frail 0.03 (0.003, 0.25) 0.002 0.03 (0.003, 0.34) 0.004 0.02 (0.001, 0.73) 0.033
Birth ordere
Non-frail ref. ref. ref.
Pre-frail 1.09 (0.85, 1.41) 0.486 1.14 (0.88, 1.47) 0.319 1.13 (0.87, 1.47) 0.350
Frail 1.59 (0.82, 3.06) 0.168 1.83 (0.94, 3.58) 0.076 1.83 (0.95, 3.53) 0.088
Mother’s BMI in late pregnancy
Non-frail ref. ref. ref.
Pre-frail 1.11 (0.85, 1.45) 0.455 0.97 (0.93, 1.02) 0.252 0.95 (0.91, 1.00) 0.062
Frail 1.04 (0.93, 1.17) 0.462 1.04 (0.98, 1.10) 0.534 0.99 (0.89, 1.11) 0.909
Note. RRR=relative risk ratio, BMI=body mass index. a Adjusted for sex and age. b Adjusted for 
Model 1 plus gestational age and childhood and adult SES. c Adjusted for Model 2 plus adult BMI, 
smoking, hypertension and diabetes. d Quadratic term included. e First born vs. second or later.
To asses which of the individual frailty criteria were driving the observed
associations between early life determinants and frailty, additional analyses 
were performed focusing upon the individual criteria. Results from these
analyses are shown in Table 10. Inverse associations between birth weight, 
birth length and birth BMI and the criteria of exhaustion, low physical activity 
and weakness were found. 
The corresponding odds ratios (OR’s) of meeting the criteria of exhaustion 
and weakness were decreased (age- and sex-adjusted OR’s 0.60, 95% CI 0.37, 
0.99; p=0.049 and 0.67, 95% CI 0.48, 0.94; p=0.020, respectively) per 1 kg 
increase in birth weight. The associations became non-significant after 
adjustment for potential mediators. Birth BMI was also associated with 
exhaustion and weakness, however, associations persisted after adjustment 
for sex, age, childhood and adult SES, adult BMI, smoking, hypertension and 
diabetes (adjusted OR’s 0.12, 95% CI 0.02, 0.59; p=0.010 and 0.14, 95% CI 
0.03, 0.71; p=0.018, respectively) for exhaustion and weakness.
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In a similar fashion, a 1 cm increase in birth length was associated with a 
decreased OR of fulfilling the criteria of low physical activity and weakness
(age- and sex-adjusted OR’s 0.89, 95% CI 0.80, 0.99; p=0.026 and 0.91, 95% 
CI 0.84, 0.98; p=0.017, respectively). While the association between birth 
length and weakness became non-significant after additional adjustment, the 
association between birth length and low physical activity was little changed
(OR 0.88, 95% CI 0.78, 0.99; p=0.030) after adjustment for potential 
confounders. No associations between body size at birth and the criteria of 
weight loss and slowness were observed.
Odds ratios of selected frailty criteria per one-unit increases (kg, cm, and kg/m2)
in early life characteristics.
Model 1a Model 2b Model 3c




Exhaustion 0.60 (0.37, 
0.99)
0.049 0.67 (0.38, 
1.15)
0.146 0.67 (0.38, 
1.18)
0.166
Weight loss 0.97 (0.55, 
1.72)
0.924 1.12 (0.59, 
2.15)
0.495 1.11 (0.57, 
2.15)
0.763
Low physical activity 0.83 (0.53, 
1.29)
0.411 0.83 (0.51, 
1.36)
0.467 0.80 (0.48, 
1.32)
0.384
Slowness 0.84 (0.61, 
1.17)
0.309 0.86 (0.59, 
1.25)
0.431 0.84 (0.57, 
1.23)
0.372
Weakness 0.67 (0.48, 
0.94)
0.020 0.73 (0.51, 
1.06)




Exhaustion 0.93 (0.82, 
1.04)
0.202 0.94 (0.83, 
1.08)
0.388 0.95 (0.84, 
1.09)
0.490
Weight loss 0.95 (0.83, 
1.09)
0.475 0.99 (0.86, 
1.17)
0.991 1.00 (0.86, 
1.17)
0.987
Low physical activity 0.89 (0.80, 
0.99)
0.026 0.88 (0.78, 
0.99)
0.035 0.88 (0.78, 
0.99)
0.030
Slowness 0.94 (0.87, 
1.01)
0.108 0.92 (0.85, 
1.01)
0.080 0.92 (0.84, 
1.01)
0.080
Weakness 0.91 (0.84, 
0.98)
0.017 0.92 (0.84, 
1.01)




Exhaustion 0.08 (0.02, 
0.39)
0.002 0.10 (0.02, 
0.50)
0.005 0.12 (0.02, 
0.59)
0.010
Weight loss 1.31 (0.07, 
26.39)
0.861 1.50 (0.09, 
23.98)
0.774 1.88 (0.10, 
34.00)
0.670
Low physical activity 0.22 (0.04, 
1.19)
0.079 0.22 (0.04, 
1.30)





Slowness 0.39 (0.07, 
1.17)
0.081 0.40 (0.09, 
1.71)
0.216 0.45 (0.10, 
1.97)
0.292
Weakness 0.09 (0.02, 
0.49)
0.005 0.12 (0.02, 
0.65)
0.014 0.14 (0.03, 
0.71)
0.018
Note. OR=odds ratio, BMI=body mass index. a Adjusted for sex and age. b Adjusted for Model 1 plus 
gestational age and childhood and adult SES. c Adjusted for Model 2 plus adult BMI, smoking, 
hypertension and diabetes. d Quadratic term included.
Serial measurements of weight and height of the cohort members at ages 1, 2, 
7 and 11 years are shown in Table 11. Differences in size originating from birth 
(Table 8) in which the boys were heavier, taller and had a higher BMI than the 
girls, persisted into childhood but had levelled off by age 11 years. Besides
associations between body size at birth and frailty (Table 9), no associations 
between size at 1, 2, 7 or 11 years and frailty in old age were observed. When 
birth weight was divided into thirds and BMI at the age of 11 years into three 
groups, the prevalence of frailty was higher (8.6%) than the cohort average 
(2.7%) among men who both belonged in the lowest third of birth weight and 
at the age of 11 years, to the group with the highest BMI (>17.5kg/m2) (data 
not shown).
Conditional growth was calculated for the periods of 0-6 months, 6-24
months and 2-11 years (Table 12). Conditional growth was not associated with 
frailty apart from an association between conditional BMI gain from 2-11 years 
and frailty in men (RRR 2.36, 95% CI 1.21, 4.64; p=0.012), which was 
attenuated after additional adjustment (RRR 2.07, 95% CI 0.94, 4.56; 
p=0.072).
Serial measurements of body size (1, 2, 7 and 11 years) of the cohort members.
Whole cohort Men Women
n Mean (SD) n Mean (SD) n Mean (SD) pa
Size at 1 year
Weight (kg) 1078 10.2 (1.0) 475 10.5 (1.0) 603 9.9 (1.0) <0.001
Height (cm) 1078 75.7 (2.6) 475 76.7 (2.4) 603 75.0 (2.4) <0.001
BMI (kg/m2) 1078 17.7 (1.4) 475 17.9 (1.4) 603 17.5 (1.3) <0.001
Size at 2 years
Weight (kg) 1078 12.1 (1.1) 475 12.4 (1.1) 603 11.9 (1.1) <0.001
Height (cm) 1078 86.2 (3.0) 475 86.8 (2.9) 603 85.6 (2.9) <0.001
BMI (kg/m2) 1078 16.5 (1.2) 475 16.7 (1.2) 603 16.4 (1.2) 0.001
Size at 7 years
Weight (kg) 1038 22.4 (2.7) 461 22.7 (2.5) 577 22.3 (2.8) 0.022
Height (cm) 1038 120.6 (4.6) 461 121.1 (4.7) 577 120.1 (4.5) 0.001
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BMI (kg/m2) 1038 15.5 (1.2) 461 15.5 (1.1) 577 15.5 (1.3) 0.623
Size at 11 years
Weight (kg) 1041 34.1 (5.0) 459 33.9 (4.3) 582 34.2 (5.5) 0.354
Height (cm) 1040 141.8 (6.1) 459 141.8 (5.6) 581 141.7 (6.4) 0.798
BMI (kg/m2) 1039 16.9 (1.7) 458 16.9 (1.4) 581 17.0 (1.9) 0.199
Note. SD=standard deviation, BMI=body mass index. a Difference between men and women.
RRR’s of frailty according to conditional weight, height in all participants and BMI 
gain by sex.
Non-frailty Frailty
Model 1a Model 2b
Ref. RRR (95% CI) p RRR (95% CI) p
Conditional weight gain
0-6 months 0.93 (0.66, 1.33) 0.700 0.95 (0.65, 1.40) 0.795
6-24 months 0.99 (0.71, 1.38) 0.949 1.12 (0.77, 1.65) 0.552
2-11 years 1.14 (0.83, 1.58) 0.412 0.97 (0.68, 1.37) 0.859
Conditional height gain
0-6 months 1.06 (0.76, 1.50) 0.723 1.11 (0.78, 1.58) 0.565
6-24 months 0.90 (0.64, 1.26) 0.541 0.98 (0.68, 1.41) 0.906
2-11 years 1.00 (0.71, 1.40) 0.982 0.93 (0.65, 1.32) 0.687
Conditional BMI gainc
0-6 months
Men 0.89 (0.49, 1.60) 0.694 0.88 (0.46, 1.67) 0.688
Women 0.75 (0.48, 1.16) 0.196 0.80 (0.50, 1.29) 0.360
6-24 months
Men 0.72 (0.38, 1.36) 0.310 0.98 (0.47, 2.06) 0.963
Women 1.29 (0.84, 1.96) 0.241 1.25 (0.79, 1.98) 0.332
2-11 years
Men 2.36 (1.21, 4.64) 0.012 2.07 (0.94, 4.56) 0.072
Women 1.03 (0.70, 1.49) 0.894 0.91 (0.60, 1.38) 0.653
Note. RRR=relative risk ratio, CI=confidence interval, BMI=body mass index. a Adjusted for age 
and sex. b Adjusted for Model 1 plus gestational age, childhood and adult socioeconomic status 
(SES), adult BMI, smoking, hypertension and diabetes. c Model 1 adjusted for age only.
Additional analyses for the individual frailty criteria were performed to 
determine the existence of associations between body size at 1, 2, 7 and 11 years 
and frailty that could not be detected in changes in the frailty classification.
While no associations between body size and exhaustion, weight loss, low 
physical activity and slowness were observed, bigger size at 1, 2 and 7 years 
corresponded with a decreased OR of fulfilling the criterion of weakness at the 
mean age of 71 years (Table 13). No associations between conditional growth 
measured for the periods of 0-6 months, 6-24 months and 2-11 years and any 
of the criteria were observed.
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50
Odds ratios of weakness according to measurements of body size (1, 2, 7 and 11 
years) of the cohort members
Model 1a Model 2b
OR (95% CI) p OR (95% CI) p
Size at 1 year
Weight (kg) 0.83 (0.71, 0.98) 0.027 0.85 (0.71, 1.00) 0.053
Height (cm) 0.96 (0.90, 1.02) 0.169 0.96 (0.90, 1.02) 0.176
BMI (kg/m2) 0.92 (0.82, 1.03) 0.155 0.93 (0.83, 1.05) 0.243
Size at 2 years
Weight (kg) 0.84 (0.72, 0.96) 0.014 0.85 (0.73, 0.98) 0.026
Height (cm) 0.97 (0.91, 1.02) 0.231 0.97 (0.92, 1.02) 0.223
BMI (kg/m2) 0.85 (0.75, 0.97) 0.019 0.87 (0.76, 0.99) 0.041
Size at 7 years
Weight (kg) 0.92 (0.86, 0.98) 0.006 0.92 (0.86, 0.98) 0.009
Height (cm) 0.97 (0.93, 0.99) 0.042 0.96 (0.93, 0.99) 0.029
BMI (kg/m2) 0.96 (0.76, 0.99) 0.032 0.88 (0.76, 1.01) 0.067
Size at 11 years
Weight (kg) 0.97 (0.94, 1.01) 0.109 0.98 (0.94, 1.01) 0.160
Height (cm) 0.98 (0.95, 1.00) 0.062 0.98 (0.95, 1.00) 0.059
BMI (kg/m2) 0.97 (0.88, 1.06) 0.477 0.98 (0.89, 1.08) 0.694
Note. OR=odds ratio, CI=confidence interval, BMI=body mass index. a Adjusted for age and sex. b
Adjusted for Model 1 plus gestational age, childhood and adult socioeconomic status (SES), adult 
BMI, smoking, hypertension and diabetes.
The study cohort in this sub-study consisted of 972 individuals, of whom 117 
(12.0 %) had experienced wartime separation from both parents in childhood.
The separated cohort members were on average heavier at birth (3.47 and 3.41 
kg) and had reported a higher prevalence of hypertension in adulthood (41.9 
and 30.4 %) compared to the non-separated individuals (n=855) who served 
as controls (p- The mean age at separation was 4.2 years (SD 2.2) 
and, on average, the separated spent 1.6 years (SD 1.0) with their new foster 
families. At the mean age of 71 years, the percentage of frail individuals was 
5.1 % for the separated cohort and 3.2 % for the non-separated cohort 
(ptrend=0.310). The prevalence of frailty was higher among the separated men 
(7.1 %) than the non-separated men (2.3 %, p=0.048). No differences in frailty 
criteria were observed between the separated and the non-separated cohort
members in comparisons for both sexes combined and when analysed 
separately for men and women.
In Table 14, compared to the non-separated men, men experiencing 
wartime separation in childhood had an increased risk of frailty (age-adjusted 
RRR 3.93, 95% 1.02, 15.11; p=0.046) compared to the non-frail men, which 
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persisted after additional adjustments for confounders (RRR 5.18, 95% CI 1.16, 
23.17; p=0.031). This was not observed among women (RRR 0.61, 95% CI 
0.13, 2.94; p=0.550).
Relative risk ratios of frailty among the separated compared to the non-separated.
Model 1a Model 2b




Men 3.93 (1.02, 15.11) 0.046 5.18 (1.16, 23.17) 0.031
Women 0.62 (0.13, 2.94) 0.550 0.58 (0.26, 1.31) 0.502
Note. RRR=relative risk ratio, CI=confidence interval. a Adjusted for age. b Adjusted for Model 1 
plus birth weight, childhood and adult SES, adult BMI, smoking, hypertension and diabetes.
The age at and duration of the separation was studied further for the separated 
men. Younger age at separation (before the age of 4 years) was associated with 
an increased age-adjusted RRR of frailty (RRR 5.58, 95% CI 1.36, 22.93; 
p=0.017) compared to the non-separated men. Further adjustment for birth 
weight, childhood and adult SES, adult BMI, smoking, hypertension and 
diabetes had little effect on the association (RRR 6.96, 95% CI 1.28, 37.72; 
p=0.024). No data was available for those separated at an older age (at the age 
of 4 or older). The RRR of frailty was further increased with prolonged
duration of the stay with the new foster family: compared to the non-separated 
men, men who spent more than 2 years abroad had an increased RRR of frailty 
(RRR 10.27, 95% CI 1.71, 61.68; p=0.011), which persisted after adjusting for 
covariates (RRR 12.87, 95% CI 1.29, 128.38; p=0.029). This was not seen for 
durations of 2 years or less (age-adjusted RRR 2.66, 95% CI 0.28, 25.15; 
p=0.392). In boys, no associations between separation status and any of the 
criteria of frailty were observed.
RRR’s of frailty according to childhood and adult SES are shown in Tables 15
and 16, respectively. Individuals coming from families of manual workers had 
an increased RRR of pre-frailty (age- and sex-adjusted RRR 1.46, 95% CI 1.05, 
2.04; p=0.025) compared to participants from upper middle class 
backgrounds. Further adjustments, first for adult SES and additionally for 
adult BMI, smoking, hypertension and diabetes, resulted in an attenuation of 




In terms of adult SES, a graded increase in the risk of pre-frailty (RRR 1.82, 
95% CI 1.23, 2.68; p=0.003) and frailty (age and sex adjusted RRR 3.18, 95% 
CI 1.15, 8.80; p=0.026) compared to non-frailty was observed among those 
classified as manual workers compared to those who were classified as upper 
middle class persons. When the comparison was performed for those classified 
as having a lower middle class working history relative to those with an upper 
middle class SES, a similar trend was observed. However, after performing 
additional adjustments for potential confounders, only associations 
comparing lower and upper middle class SES remained statistically significant 
(fully adjusted RRR of frailty 3.81, 95% CI 1.69, 8.58; p=0.001).
Relative risk ratios of frailty and pre-frailty according to childhood SES compared 
to the non-frail individuals of the cohort.
Model 1a Model 2b Model 3c
RRR (95% CI) p RRR (95% CI) p RRR (95% CI) p
Childhood SES
Upper middle class (Ref.)
Lower middle class
Non-frailty Ref. Ref. Ref.
Pre-frailty 1.14 (0.84, 1.55) 0.416 1.08 (0.79, 1.48) 0.618 1.12 (0.81, 1.55) 0.488
Frailty 1.57 (0.67, 3.70) 0.302 1.49 (0.62, 3.57) 0.368 1.36 (0.55, 3.36) 0.508
Manual workers
Non-frailty Ref. Ref. Ref.
Pre-frailty 1.46 (1.05, 2.04) 0.025 1.30 (0.92, 1.84) 0.135 1.25 (0.88, 1.78) 0.223
Frailty 2.04 (0.77, 5.42) 0.153 1.57 (0.57, 4.35) 0.384 1.12 (0.39, 3.23) 0.837
Note. RRR=relative risk ratio, CI=confidence interval, SES=socioeconomic status. a Adjusted for 
sex and age. b Adjusted for Model 1 plus adult SES. c Adjusted for Model 2 plus adult BMI, smoking, 
hypertension and diabetes.
Relative risk ratios of frailty and pre-frailty according to adult SES compared to 
the non-frail individuals of the cohort.
Model 1a Model 2b Model 3c
RRR (95% CI) p RRR (95% CI) p RRR (95% CI) p
Adulthood SES
Upper middle class (Ref.)
Lower middle class
Non-frailty Ref. Ref. Ref.
Pre-frailty 1.50 (1.10, 2.05) 0.010 1.47 (1.08, 2.01) 0.016 1.35 (0.98, 1.87) 0.067
Frailty 4.26 (1.97, 9.24) <0.001 4.11 (1.89, 8.97) <0.001 3.81 (1.69, 8.58) 0.001
Self-employed
Non-frailty Ref. Ref. Ref.
Pre-frailty 1.73 (1.06, 2.84) 0.030 1.63 (0.99, 2.69) 0.055 1.70 (1.01, 2.88) 0.047
Frailty 4.31 (0.97, 19.17) 0.055 3.85 (0.86, 17.35) 0.079 4.27 (0.92, 19.82) 0.064
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Manual workers
Non-frailty Ref. Ref. Ref.
Pre-frailty 1.82 (1.23, 2.68) 0.003 1.68 (1.12, 2.50) 0.012 1.46 (0.96, 2.22) 0.074
Frailty 3.18 (1.15, 8.80) 0.026 2.71 (0.94, 7.77) 0.064 2.41 (0.79, 7.32) 0.120
Note. RRR=relative risk ratio, CI=confidence interval, SES=socioeconomic status. a Adjusted for 
sex and age. b Adjusted for Model 1 plus childhood SES. c Adjusted for Model 2 plus adult BMI, 
smoking, hypertension and diabetes.
The cohort members’ telomere measurements are presented in Table 17. 
Women had longer relative LTL at both the mean age of 61 years (1.42 and 1.37 
T/S units) and 71 years (0.90 and 0.81 T/S units) compared to the men (p-
values<0.03). On average, relative LTL was 37.1% (SD 24.5) shorter compared 
to that measured 10 years earlier, with men losing on average a greater 
percentage of their relative LTL than women (p=0.006). 
Measurements of telomere length and telomere shortening in the cohort.
Whole cohort Men Women
n Mean (SD) n Mean (SD) n Mean (SD) pa
Telomere length
LTL at 61 years 
(T/S ratio)
1042 1.40 (0.29) 458 1.37 (0.29) 584 1.42 (0.29) 0.029
LTL at 71 years (T/S 
ratio)
1061 0.86 (0.30) 465 0.81 (0.27) 596 0.90 (0.32) <0.001
Telomere shortening rate
Between 61-71 years 
(change T/S ratio)
1037 -0.54 (0.36) 455 -0.57 (0.35) 582 -0.52 (0.37) 0.047
Between 61-71 years 
(change T/S ratio 
percent)
1037 -37.1 (24.5) 455 -39.5 (23.2) 582 -35.3 (25.3) 0.006
Note. SD=standard deviation, LTL=leukocyte telomere length. a Difference between men and 
women.
A graded decreasing trend in relative LTL was observed among non-frail, pre-
frail and frail individuals with the mean age of 61 years (ptrend=0.016) and 71 
years (ptrend=0.057) in the whole cohort (Figure 6). Cross-group comparisons 
between the non-frail and frail participants were borderline significant at both 
time points (both p-values=0.064). However, no trend in T/S shortening rate, 




Relative LTL in people with the mean age of 61 years was associated with frailty
in people with the mean age of 71 years, illustrated in Table 18. A one-unit 
increase in the T/S ratio corresponded with a decreased risk of frailty (RRR 
0.24, 95% CI 0.07, 0.83; p=0.024) when non-frailty was selected as the 
reference category in age- and sex-adjusted analyses. The association was little 
changed after further adjustment for adult SES, body fat percentage, smoking 
habits, cardiovascular disease and diabetes, RRR being 0.28 (95% CI 0.08, 
0.97; p=0.045).
An inverse association between relative LTL and frailty at the mean age of 
71 years was observed, adjusting for age and sex. Per each unit increase in the 
T/S ratio the RRR of frailty was 0.16 (95% CI 0.04, 0.73; p=0.018) compared 
to the non-frail individuals. Further adjustments for confounders (RRR 0.25, 
95% CI 0.06, 1.10; p=0.067) as well as relative LTL at the mean age of 61 years 
(RRR 0.27, 95% CI 0.06, 1.26; p=0.096) resulted in attenuation of the 
association between relative LTL and frailty at the average age of 71 years.
Relative risk ratios of frailty according to increasing telomere length and 
shortening.
Model 1a Model 2b
RRR (95% CI) p RRR (95% CI) p
LTL at the mean age of 61 years
Non-frail Ref. Ref.
Pre-frail 0.65 (0.42, 1.01) 0.057 0.69 (0.43, 1.10) 0.117
Frail 0.24 (0.07, 0.83) 0.024 0.28 (0.08, 0.97) 0.045
LTL at the mean age of 71 years
Non-frail Ref. Ref.
Pre-frail 0.82 (0.54, 1.26) 0.371 0.87 (0.56, 1.36) 0.549
Frail 0.16 (0.04, 0.73) 0.018 0.25 (0.06, 1.10) 0.067
LTL at the mean age of 71 yearsc
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Non-frail Ref. Ref.
Pre-frail 0.92 (0.59, 1.43) 0.710 0.95 (0.60, 1.51) 0.824
Frail 0.27 (0.06, 1.26) 0.096 0.39 (0.09, 1.78) 0.138
T/S ratio percent shortening between 61 and 71 yearsc
Non-frail Ref. Ref.
Pre-frail 1.00 (0.99, 1.01) 0.963 1.00 (0.99, 1.01) 0.890
Frail 0.98 (0.96, 1.00) 0.075 0.99 (0.97, 1.01) 0.188
Note. RRR=relative risk ratio, LTL=leukocyte telomere length, SES=socioeconomic status. a
Adjusted for sex and age. b Adjusted for Model 1 plus adult SES, adult body fat percentage, smoking, 
cardiovascular disease and diabetes. c Adjusted additionally for LTL at the mean age of 61 years.
The association between relative LTL and telomere shortening and frailty was 
further studied for the individual frailty criteria. While no associations 
between telomere measurements and exhaustion, weight loss, low physical 
activity and weakness were observed, the criterion of slowness seemed to be 
driving the association between telomere measurements and frailty (Table 19). 
This association was different for men and women, as indicated by the 
interactions between sex and telomere measurements on slowness
(interaction p-values <0.05). In women, a one-unit increase in the relative LTL 
T/S ratios at 61 and 71 years were associated with slowness (age-adjusted OR’s 
0.30, 95% CI 0.14, 0.63; p=0.002 and 0.40, 95% CI 0.19, 0.87; p=0.020, 
respectively). The association between relative LTL at the mean age of 61 years 
and slowness changed only little after further adjustment for potential 
confounders, OR 0.33 (95% CI 0.15, 0.73; p=0.006), however, the association 
between LTL measured at the average of 71 years and slowness was attenuated 
after additional adjustment. This was not observed in men. No associations 
between telomere shortening and slowness were observed.
Odds ratios of fulfilling the frailty criterion of slowness according to increasing 
telomere length and shortening.
Model 1a Model 2b
OR (95% CI) p OR (95% CI) p
Frailty criterion of slowness
LTL at the mean age of 61 years
Whole cohort 0.39 (0.28, 0.69) 0.001 0.42 (0.23, 0.76) 0.004
Men 0.55 (0.24, 1.26) 0.157 0.52 (0.21, 1.29) 0.158
Women 0.30 (0.14, 0.63) 0.002 0.33 (0.15, 0.73) 0.006
LTL at the mean age of 71 years
Whole cohort 0.64 (0.36, 1.12) 0.117 0.72 (0.40, 1.29) 0.271
Men 1.24 (0.54, 2.87) 0.610 1.10 (0.45, 2.69) 0.833
Women 0.40 (0.19, 0.87) 0.020 0.51 (0.23, 1.13) 0.096
LTL at the mean age of 71 yearsc
Whole cohort 0.85 (0.48, 1.48) 0.560 0.93 (0.52, 1.66) 0.794
Results
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Men 1.40 (0.61, 3.22) 0.429 1.24 (0.51, 3.04) 0.637
Women 0.60 (0.28, 1.30) 0.195 0.74 (0.33, 1.63) 0.449
T/S ratio percent shortening between 61 and 71 yearsc
Whole cohort 0.99 (0.99, 1.00) 0.496 0.99 (0.99, 1.01) 0.832
Men 1.01 (0.99, 1.02) 0.310 1.00 (0.99, 1.02) 0.417
Women 0.99 (0.98, 1.00) 0.097 0.99 (0.99, 1.01) 0.302
Note. OR=odds ratio, LTL=leukocyte telomere length, SES=socioeconomic status. a Adjusted for 
sex and age. b Adjusted for Model 1 plus adult SES, adult body fat percentage, smoking, 
cardiovascular disease and diabetes. c Adjusted additionally for LTL at the mean age of 61 years.
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The present study investigated frailty from a life-course perspective. Maternal 
characteristics and body size at birth represented prenatal influences. Serial 
measurements of weight and height from birth to childhood provided 
information on postnatal growth. Data on childhood SES was available and the 
social context of the study enabled us to study the effects of ELS on frailty in 
old age. The effects of adult SES were also studied. Ageing was studied at the 
cellular level by investigating the associations between LTL at the mean ages 
of 61 and 71 years and telomere shortening and frailty.
The results indicate that body size at birth was inversely associated with the 
incidence of frailty in that the higher the body size was at birth the lower the 
relative risk of frailty was compared to non-frailty. No associations between 
maternal BMI or birth order and frailty were observed. The boys who later 
became frail men experienced on average accelerated BMI growth in 
childhood (2-11 years) compared to the non-frail men. The girls who became 
frail women experienced growth that followed the cohort mean which was 
considered normal. 
Wartime separation from both parents in childhood, a severe form of ELS, 
was associated with frailty in boys. These results suggest that among boys, 
younger age at and longer duration of the separation could amplify the 
harmful effects of ELS on frailty. Adult SES was associated with frailty showing 
an increased risk of frailty for individuals who as adults worked in manual 
labour occupations compared to those who had worked as officials. Childhood 
SES was not related to frailty in older age.
Finally, shorter LTL at 61 years was associated with an increased risk of 
frailty at the mean age of 71 years in prospective analyses. Similarly, a cross-
sectional association between shorter LTL and frailty at 71 years was observed.
Telomere shortening during the 10-year follow-up, however, was not 
associated with frailty at the mean age of 71 years.
Based on the DOHaD hypothesis we hypothesized that maternal obesity, small
body size at birth and being first born would result in increased risk of frailty 
in old age. We observed that the findings regarding body size at birth were in 
accordance with the hypothesis.
Discussion
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Small body size at birth i.e. low weight, height and BMI at birth, may affect 
later health through the phenomenon known as programming (21). When 
nutrition is inadequate the foetus acts to prioritize growth of vital organs at 
the expense of others. For example, vital tissues in the central nervous system
such as the brain can be prioritized over tissues in the musculoskeletal system. 
Babies who are born small have less fat-free mass (88), a higher prevalence of
sarcopenia (108) and are less physically active as adults (110). Furthermore, 
small babies are at an increased risk of several chronic diseases (Table 1). The 
overlap between frailty, a geriatric syndrome, and comorbidity, which 
indicates the simultaneous prevalence of any two or more chronic disease, has 
been illustrated in the definition of frailty by Fried and colleagues (2). On the 
one hand, a higher chronic disease burden is likely to result in poorer
functioning in part through prolonged activity of mechanisms involving e.g. 
chronic inflammation. On the other, when these diseases manifest acutely, a 
more rapid progression of frailty could be expected due to inability to respond 
to a stressor.
The birth weight of the newly born is generally considered to increase with 
increasing birth order (274,275). In the present study, first born children did 
not differ from second or later born children in terms of frailty in old age. This 
could indicate that changes in birth weight, assuming that the siblings share
the same living environment, would not result in detectable changes in frailty
in first versus later born children, given that also several other factors 
contribute to birth weight (Figure 2).
Maternal obesity, defined as a high BMI (BMI>30kg/m2) recorded during 
pregnancy, has been linked with a higher prevalence of chronic diseases in the 
offspring (276,277). However, no association between maternal BMI and 
frailty was observed in the present study. It is of note that maternal obesity 
was relatively uncommon at the time the mothers of the study cohort members 
were pregnant in the 1930s and 1940s.
According to the DOHaD hypothesis, key aspects of growth that predispose an 
individual to chronic disease include the concept of mismatch. Essentially, 
growth is mismatched when postnatal circumstances are not aligned with 
what was programmed in utero. An example of mismatched growth would be 
prenatal undernutrition followed by excess of nutrition after birth.
In the present study, the association between postnatal growth and frailty 
in old age was relatively weak. No associations between size at 1, 2, 7 and 11 
years and frailty were observed. Furthermore, growth from birth to the age of 
2 years was not associated with frailty in old age. However, growth in 
childhood, i.e. from age 2 to 11 years, was associated with frailty showing 
distinct patterns of growth among boys and girls who later became frail men 
and women.
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The growth of boys who later became frail men was mismatched. They were 
small at birth after which they caught up reaching beyond the cohort average
in childhood. In late childhood, their mean Z-scores of BMI and weight were 
more than 0.3 SD above the cohort average, whereas their mean Z-scores of 
height were below the cohort average. The concept of mismatch is further 
illustrated in the prevalence of frailty according to categories of birth weight 
and BMI at age 11. The prevalence of frailty was observed to be highest among 
those who as newborns belonged to the group with the lowest birth weight, 
and at the age of 11 years, to the group with the highest BMI.
The increase in BMI without marked increases in mean height suggest that 
the increase in BMI would primarily be attributed to increases in adiposity.
There is evidence of a strong association between childhood obesity and 
obesity in adult life (278–280). Childhood obesity may have harmful and long-
lasting effects on adult morbidity (281,282). Conversely, the boys who later 
became frail men had often been small at birth. In late adulthood, obesity 
together with loss of lean mass may result in a form of obesity that is 
characterized with sarcopenia, ‘sarcopenic obesity’, which is associated with 
frailty (283). 
An interesting observation from the present study is that besides adiposity, 
postnatal growth could also be associated with frailty. While the association 
between BMI gain and frailty was attenuated in boys in the final model, further 
adjustment for adult BMI resulted in little further attenuation in the
association. This could mean that postnatal BMI gain could have modest 
independent effects on frailty in old age, i.e. effects that would not be mediated 
through BMI in adulthood. While frailty is more common among individuals 
with extremely low or high adult BMI, waist circumference has been observed 
to be associated with frailty even in ranges of normal BMI in that individuals 
with higher waist circumferences would be at increased risk of frailty (284). In 
the present study, a trend of increasing BMI with increasing grade of frailty 
was observed. Among frail individuals, BMI has been observed to mediate 
levels of inflammatory markers that lie on the pathway to ageing-related 
chronic disease (285,286).
The pattern of growth in the frail men in the present study resembles that 
observed for other chronic diseases. Therefore, it is possible that the pattern 
of growth to frailty would be linked with chronic diseases, especially because 
of attenuation of the association after controlling for key chronic diseases.
Another important point to address is the observed sex difference. 
Accelerated BMI growth in childhood was associated with frailty in boys only; 
the girls who later became frail women experienced growth within the normal 
range. Possible candidates for this difference include variation in sex 
hormones that would result in distinct body compositions with individuals in 
similar ranges of childhood BMI. Besides sex hormones, various 
environmental and epigenetic mechanisms are likely to contribute to the 
observed associations. However, due to the small numbers of frail men (n=13) 
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and women (n=26) the possibility of a chance finding cannot be excluded. 
Thus, the findings from the present study should be interpreted with caution.
There is evidence linking stressful early life events with later health outcomes.
The contribution of ELS has been most studied regarding psychiatric 
outcomes. Less is known whether ELS is associated with frailty. Based on the 
long-term associations between ELS and cortisol metabolism (287), 
inflammation (288) and telomere length (289), we hypothesized that ELS 
would predispose an individual to ageing-related disease and frailty.
Furthermore, based on previous evidence on the association between age at 
and duration of ELS and later health outcomes (266), we hypothesized that 
younger age at and longer duration of wartime separation would further
accentuate the harmful contribution of ELS.
An association between ELS and frailty was observed in men only. No 
associations were observed in women. Among men, earlier age at and longer 
duration of the separation were associated with increased risk of frailty. The 
frailty criterion of weakness seemed to be driving the association between ELS 
and frailty. The findings showed an increased risk of fulfilling the criterion of 
weakness for the separated men but a decreased risk of fulfilling the criterion 
for the separated women.
Evidence on the multiple effects that stress has on biological systems come 
from experiments done in animals (290). In ELS, stressful life experiences 
occur within a period in development that can be considered critical for later 
development. Systems that are characterized with high plasticity can be 
affected when facing these stressful events and programmed for later life. The 
effects of stress are best known for hormonal pathways e.g. the HPA-axis (121). 
On the other hand, ELS has also been associated with higher levels of 
inflammatory markers among adults (288). Lower levels of inflammatory 
markers are in fact measured among those who experience close relationships 
in their lives (291). Among war evacuees in the present study, close 
relationships and parental relations could have been disrupted. The new foster 
environment is likely to have had gene-environment interactions with the 
evacuees’ genetic factors and affected some more than others based on their 
genetic susceptibility. There is evidence to support susceptibility based on 
genetics on stress-related outcomes including depression (292). It is also 
possible that the experience of ELS could on its own result in changes in gene 
expression (293).
We did not hypothesize that the effects of ELS would depend on sex. 
However, there is mounting evidence of a sex difference in stress 
responsiveness where men would be more prone to the harmful effects of ELS
than women (294,295). Previous evidence from the HBCS suggests that 
cortisol metabolism is altered in a sex-depended manner among separated 
individuals with men reacting more powerfully to a stress test (287). When the 
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association between ELS and physical and psychosocial functioning was 
studied in the HBCS, lower functioning scores were observed among separated 
men than non-separated men but this was not observed among the women in 
the cohort (266). Another thing to support the existence of a sex difference are
the different 95% CI’s of risks of frailty for the men and women in the cohort.
Short LTL plays a role in chronic disease pathology. Research on telomere
biology supports the use of LTL as an ageing biomarker i.e. that it could give 
insight to the organism’s biological age (296). Frailty, a multi-dimensional 
geriatric syndrome, has been suggested to be a clinical presentation of 
advanced biological age (297). We hypothesized that phenomena describing 
both cellular and clinically detectable ageing would be associated with each 
other and that those with short LTL would be at risk of frailty. Furthermore, it 
was hypothesized that greater telomere shortening during a given period 
would result in accelerated cellular and even clinically detectable ageing and
frailty.
In the present study, short LTL was associated with frailty in prospective 
and cross-sectional analyses. This contradicts evidence from previous cross-
sectional studies where no associations were observed. However, during and
after the publication of results from the present study, evidence of an 
association between LTL and frailty is also increasing. The absence of 
previously observed associations could result from the use of only one LTL 
measurement in large populations where great variability in biological ageing 
and LTL is expected. 
Results from the present study support the role of LTL as a frailty 
biomarker in its ability to detect frailty-related processes. Associations 
between frailty criteria and LTL suggest that short LTL could be associated 
with aspects of physical performance including walking speed and grip 
strength. Moreover, short LTL may increase risk of chronic disease and 
multimorbidity, a state in which an individual is at increased risk of depletion 
of homeostatic reserves, potentially giving rise to frailty. At the cellular level, 
individuals with critically short telomeres are at an increased risk of 
senescence, which is a state characterized by cellular dysfunction, secretion of 
inflammatory markers and increased oxidative stress (298–300). These 
factors, namely markers of inflammation and oxidative stress, have been 
observed to be higher among frail older individuals (285,301).
We hypothesized that telomere shortening would be observed more clearly 
among frail than non-frail individuals at the end of the follow-up. However, 
no such association was observed in the present study. This could be the result 
of the dependence of telomere shortening on initial telomere length i.e. that 
individuals experiencing more telomere shortening would also have had long 
telomeres at baseline (152). Essentially, individuals undergoing accelerated 
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telomere shortening would not necessarily have short LTL which would put 
their cells at risk of senescence.
Evidence from one of the largest studies assessing age-associated telomere 
shortening suggests that most of telomere shortening would occur during the 
first decades of life after which the rate of telomere shortening would be 
relatively fixed (151). In the present study, the strength of prospective 
associations was not attenuated in the final model in contrast to cross-
sectional findings which were attenuated. LTL has not been found to be 
associated with frailty in the oldest old, which may indicate a more purposeful 
use of LTL measured at younger ages in detecting individuals that are at-risk 
of frailty.
Epidemiological cohort studies can demonstrate associations between 
multiple exposures and outcomes as well as provide estimates of prevalence 
and incidence. Birth cohorts are longitudinal studies that follow participants 
born during a certain time throughout their lives. Essentially, during this time 
a proportion of individuals are exposed to certain factors while others are not, 
and these groups are then followed up to determine the associations between 
exposures and the outcome. Although the analyses were controlled for 
potential confounders, some unmeasured confounding might still be present.
A major strength of the present study is the rich and diverse information 
available for the cohort. Several variables across the life-course could be
extracted for more than 1,000 individuals. Hospital birth records provided
information with minimal bias on the circumstances that took place at birth. 
Records held at child welfare clinics and schools had information on serial 
measurements of anthropometry. On average, 17 measurements of body size 
were available for each individual from birth to the age of 12 years.
Information on the participants’ socioeconomic circumstances and adult 
working history were obtained from Statistics Finland.
The Finnish Government has registers containing information on wartime 
evacuations conducted during WWII, and through these registers, reliable 
information on both the age at and duration of the separation was available.
However, no information on the quality of foster care was available from these 
registers. Not all evacuations were performed through the Government, and 
to find these individuals of whom no register information was available, 
questionnaires on wartime separation were administered at the clinical study 
visits. Of note is also the fact that not all evacuees returned to Finland from 
their foster families. Moreover, given this few observations of frail separated 
men (n=4) and women (n=2), the possibility of a chance finding cannot be 
excluded and thus the findings should be considered as preliminary.
A key strength of the study is the use of 2 LTL measurements. The observed 
interassay variability was particularly high (CV 21 %) at the baseline LTL 
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measurement. Some previous studies adjusted the analyses further with levels 
of inflammatory markers, which was not done in the present study due to the 
low sample size of frail individuals with information on inflammation. 
The main outcome variable of frailty was defined according to the criteria 
put forward by Fried and colleagues (2) using minor modifications. The use of 
an established frailty definition enables comparison with studies utilizing the 
same definition. Given the strict cut-offs used in the definition of frailty in the 
present study, the subsequent prevalence of frailty was lower than in other 
studies with participants of similar age (302,303). The low number of frail 
individuals was particularly challenging for the interpretation of results 
regarding early growth and ELS. We expect the number of frail individuals to 
increase as the cohort ages. Frailty was first measured at the follow-up clinical 
examination, and while it is uncertain that measuring frailty at baseline would 
have captured any frail individuals, it would be insightful in studying 
transitions between frailty classes. The used frailty definition has also received 
criticism for not including information on cognitive status, which has been 
considered in more recent definitions (304).
The cohort members were followed up to the mean age of 71 years in the 
present study. This extensively long follow-up together with clinical data 
enabled us to study associations between various factors during the life-course
and frailty in old age. The long follow-up, however, gives rise to a host of 
confounding factors. Thus, the possibility of remaining uncontrolled 
confounding cannot be excluded. The analyses were adjusted for key lifestyle 
factors and chronic diseases.
While all participants had been born in Helsinki between the years 1934 
and 1944, only those who visited child welfare clinics during those times were 
included. Similarly, participation in the baseline and follow-up clinical
examinations was voluntary. At every step, those in poor health may have been 
less keen on participating, resulting in loss to follow-up, selective survival and 
an underrepresentation of frail individuals. Therefore, associations found in 
the study could be underestimations.
The world is quite different now in comparison with what it was in the 
1930’s and 1940’s. Finland, having gone through rapid industrialization, has 
transitioned from a developing to a highly developed country. Similarly, the 
availability of food and eating culture as a whole have undergone considerable 
changes. For example, for the present cohort, undernutrition may have been a 
bigger problem than for more contemporary cohorts battling with childhood 
obesity. Cohort effects may limit generalizability of the results to other more 
contemporary populations.
Results from the present study add to the understanding of frailty and of the 
contribution that early life risk factors have on the syndrome. The associations 
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between body size at birth and frailty suggest that susceptibility to frailty may 
be programmed as early on as in utero. The influence of the prenatal 
environment on frailty was modified by postnatal growth, however to a minor
extent. Early life stress was associated with frailty in men only. This 
vulnerability found particularly in men could be the result of reprogramming 
of the HPA-axis and consequent changes to cortisol metabolism. The 
association between LTL and frailty implies that cellular senescence and 
lifespan may be involved in the cellular mechanisms that eventually may give 
rise to clinical frailty. LTL could be a meaningful frailty biomarker.
Chronic disease prevention should start at a younger age. Studying chronic
diseases from a life-course perspective gives insight into the importance of 
different risk factors during different sensitive periods in the life-course.
Through promotion of health of the mother, her baby, and consequent growth 
of the infant and child, the risk of later chronic disease and frailty may be 
reduced. The information provided in this thesis can be used to identify at-risk 
groups of individuals who may have an increased risk of chronic illnesses and 
who may benefit from disease prevention.
Cohort effects and the historical context of the present study may limit the 
generalizability of the results. However, in birth cohorts worldwide, the 
incidence of frailty is very low given the fact that frailty starts to become
increasingly prevalent after the 7th decade. The findings should be confirmed 
in more contemporary cohorts.
The proportion of frail individuals is expected to increase as the mean age 
of HBCS participants increases. Follow-up studies may have enough power to 
clarify the sex differences found regarding early growth and early life stress.
The low proportion of frail individuals in the cohort may have limited the 
interpretation of the results. The third clinical examination of the cohort 
members, which is ready by the end of year 2018, will enable analyses that 
explore change in frailty longitudinally within the same individuals and the 
contribution of life course risk factors on transitions between frailty 
categories. This would be particularly interesting regarding study IV where 
more high-quality studies are needed to determine whether short LTL 
precedes frailty.
Besides studying associations between early predictors and frailty in old 
age it would be of interest to investigate the future health of frail participants
of the cohort. Longitudinal studies between frailty and clinical measurements 
including blood pressure, glucose tolerance and cholesterol levels could give 
insight into the effects of frailty on commonly used health indicators.
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The present study investigated frailty determinants from a life-course 
perspective. Following conclusions could be drawn from the studies:
1. Susceptibility to frailty may in part be programmed early in life, 
illustrated in the inverse association between body size at birth and 
frailty in old age.
2. Childhood SES was not associated with frailty but adult SES was, 
suggesting that those with poor socioeconomic status in adult life could 
be at an increased risk of frailty.
3. The growth of boys who became frail men was mismatched showing 
increased BMI gain in childhood. The association was independent of 
adulthood BMI.
4. Boys experiencing ELS were more often frail men in old age. No 
associations were observed among women, suggesting that the 
association between ELS and frailty could vary by sex.
5. LTL was associated with frailty in prospective and cross-sectional 
analyses, suggesting that cellular lifespan and senescence could be
involved in frailty pathophysiology. Furthermore, the results suggest 
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